Editor's Pick: The week ahead....
(E2V.L) e2v technologies PLC Buy/Sell
81.00
+5.75
(7.64%)
Add to portfolio
Set Alert
Level 2
Desktop Trader
News
Be automatically updated! Get company news by RSS.
Click here for the feed: RSS Feed or learn more about the benefits RSS
| Date/Time | Headline | Source |
|---|---|---|
| 1 |  2 | ||
| Fri 16:40 | RNS |
|
|
RNS Number : 8776C e2v technologies PLC 20 November 2009 A second and final Price Monitoring Extension has been activated in this security. The closing auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still execute more than a pre-determined percentage above or below the price of the previous automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction call execution which will set today's closing price. The applicable percentage is set by reference to a security's TradElect sector. This is set out in the Sector Breakdown tab of the TradElect Parameters document at www.londonstockexchange.com/en-gb/products/membershiptrading/tradingservices</f ipP> This information is provided by RNS The company news service from the London Stock Exchange END
APMPUGUCGUPBGQU More |
||
| Fri 16:35 | RNS |
|
|
RNS Number : 8770C e2v technologies PLC 20 November 2009 Today's closing auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security during the initial auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the last automated execution today. The applicable percentage is set by reference to a security's TradElect sector. This is set out in the Sector Breakdown tab of the TradElect Parameters document at www.londonstockexchange.com/en-gb/products/membershiptrading/tradingservices</f ipP> This information is provided by RNS The company news service from the London Stock Exchange END
PMEBLBDBUXDGGCG More |
||
| Fri 10:34 | RNS |
|
|
RNS Number : 8423C e2v technologies PLC 20 November 2009 20 November 2009 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCED HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES.
E2V TECHNOLOGIES PLC
RESULTS OF GENERAL MEETING The Board is pleased to announce that at the General Meeting of e2v technologies plc held this morning all the resolutions (the "Resolutions") put to the General Meeting in connection with the Firm Placing and the Rights Issue were duly passed, without amendment, by the required majority on a show of hands. Full details of the Resolutions are set out in the Notice of General Meeting contained in the prospectus published by the Company and sent to shareholders on 2 November 2009 (the "Prospectus"), a copy of which is available on the Company's website. A summary of the proxy votes received in advance of the General Meeting in respect of the Resolutions is set out below. Total number of shareholders voting: 150 representing approximately 50,668,012 Ordinary Shares amounting to approximately 80.98% of the issued ordinary share capital of the Company.
Directors of the Company to
allot Ordinary Shares in
connection with the Firm
Placing and the Rights Issue
pre-emption rights in relation
to the allotment of Ordinary
Shares pursuant to the Firm
Placing and the Rights Issue
terms of the Firm Placing
subscription by Aberforth for Firm Placed Shares In accordance with the Listing Rules, copies of the Resolutions will shortly be available for inspection at the Financial Services Authority's Document Viewing Facility which is situated at: Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS It is expected that admission of the Firm Placed Shares and the New Shares (nil paid) to the Official List and to trading on the London Stock Exchange's main market for listed securties and commencement of dealings in the Firm Placed Shares and New Shares (nil paid) will become effective at 8.00 a.m. on 23 November 2009. It is further expected that Provisional Allotment Letters in relation to the New Shares (nil paid), pursuant to the Rights Issue will be posted to Qualifying Non-CREST Shareholders (other than Excluded Overseas Shareholders) later today and Nil Paid Rights are expected to be credited to stock accounts, and enabled for settlement, in CREST for Placees and Qualifying CREST Shareholders (other than Excluded Overseas Shareholders) on 23 November 2009. The latest time and date for acceptance and payment in full under the Rights Issue is 11.00 a.m. on 7 December 2009. For full details of the timetable for, and the terms and conditions of, the Firm Placing and the Rights Issue please refer to the Prospectus. Terms defined in the Prospectus have the same meanings in this announcement. Enquiries:
Keith Attwood, Chief Executive Charles Hindson, Group Finance Director www.e2v.com THIS ANNOUNCEMENT SHALL NOT CONSTITUTE, OR FORM PART OF, AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, NOR SHALL THERE BE ANY SALE OR PURCHASE OF SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THE AVAILABILITY OF THE FIRM PLACING AND THE RIGHTS ISSUE TO PERSONS NOT RESIDENT IN THE UNITED KINGDOM MAY BE AFFECTED BY THE LAWS OF THE RELEVANT JURISDICTIONS. SUCH PERSONS SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE REQUIREMENTS. This announcement is not for publication, distribution or release to persons in the United States, Australia, Canada, Japan, New Zealand, South Africa or Switzerland and should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered, sold, resold, taken up, exercised, renounced, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. No public offering of the securities referred to herein is being made in the United States. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. This information is provided by RNS The company news service from the London Stock Exchange END
MSCBGBDBDXDGGCG More |
||
| 10-11-09 | RNS |
|
|
RNS Number : 2861C e2v technologies PLC 10 November 2009 e2v technologies plc 10 November 2009 Total Voting Rights In conformity with the Transparency Directive's transitional provision 6, the Company would like to notify the market of the following: The Company's issued share capital consists of 62,569,593 Ordinary Shares of 5p each with one voting right per share. The total number of shares in the Company with voting rights is therefore 62,569,593. The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock Exchange END
TVREADFEFSANFFE More |
||
| 06-11-09 | RNS |
|
|
RNS Number : 1310C e2v technologies PLC 06 November 2009
PRESS RELEASE 06 November 2009 e2v technologies PLC Re: Prospectus NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCE HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES. e2v technologies plc (the "Company") The Company wishes to announce a clarification in respect of a statement contained in the prospectus dated 2 November 2009 (the "Prospectus") relating to the proposed Firm Placing of 31,428,571 Firm Placed Shares at 70 pence per Firm Placed Share and 9 for 7 Rights Issue of 120,854,782 New Shares at 28 pence per share. Pages 6 and 38 of the Prospectus contain the following identical statement in relation to Related Party Transactions as follows: "Aberforth is considered to be a related party to the Company because the aggregate shareholding of it and its associates is in excess of 10% of the Company's existing issued share capital. Aberforth has undertaken to participate in the Firm Placing through the acquisition of 6,800,514 Firm Placed Shares and to take up its rights under the Rights Issue." The Company wishes to clarify that Aberforth has undertaken to take up those rights arising from the acquisition of 6,800,514 Firm Placed Shares but has not given any undertaking in relation to rights over its existing Shares. Terms defined in the Prospectus have the same meanings in this announcement. THIS ANNOUNCEMENT SHALL NOT CONSTITUTE, OR FORM PART OF, AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, NOR SHALL THERE BE ANY SALE OR PURCHASE OF SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THE AVAILABILITY OF THE FIRM PLACING AND THE RIGHTS ISSUE TO PERSONS NOT RESIDENT IN THE UNITED KINGDOM MAY BE AFFECTED BY THE LAWS OF THE RELEVANT JURISDICTIONS. SUCH PERSONS SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE REQUIREMENTS. This announcement is not for publication, distribution or release to persons in the United States, Australia, Canada, Japan, New Zealand, South Africa or Switzerland and should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered, sold, resold, taken up, exercised, renounced, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. No public offering of the securities referred to herein is being made in the United States. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus.
ExecutiveCharles Hindson, Group Finance Director
HimsworthRoger HemmingJohn Byrne
Corporate Broking: John MacGowanAlexander
GartonSyndication:Lee Morton
This information is provided by RNS The company news service from the London Stock Exchange END
PDIILFIVLDLRIIA More |
||
| 05-11-09 | RNS |
|
|
RNS Number : 0688C e2v technologies PLC 05 November 2009 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: e2v technologies plc 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (X) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: Lloyds Banking Group plc 4. Full name of shareholder(s) (if different from 3.) : 4,838,829 shares (7.734%) are under control of Scottish Widows Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widow Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group plc (direct/indirect interests) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 3/11/2009 6. Date on which issuer notified: 5/11/2009 7. Threshold(s) that is/are crossed or reached: Direct / Indirect holdings remain above 8% 8. Notified details: A: Voting rights attached to shares
possible using the ISIN CODE
ISIN GB00B01DW905 Resulting situation after the triggering transaction
possible using the ISIN CODE
ISIN GB00B01DW905 B: Financial Instruments Resulting situation after the triggering transaction
Total (A+B) Number of voting rights % of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
As question 4 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: Notification using the total voting rights figure of 62,569,593 14. Contact name: Charlotte Parmenter 15. Contact telephone number: 01245-453643 This information is provided by RNS The company news service from the London Stock Exchange END
HOLUVANRKKRARAA More |
||
| 04-11-09 | RNS |
|
|
RNS Number : 9814B e2v technologies PLC 04 November 2009 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: e2v technologies plc 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (X) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: Lloyds Banking Group plc 4. Full name of shareholder(s) (if different from 3.) : 3,838,829 shares (6.135%) are under control of Scottish Widows Investment Partnership Ltd, a wholly owned subsidiary of Scottish Widow Group Ltd, a wholly owned subsidiary of Lloyds TSB Bank plc, a wholly owned subsidiary of Lloyds Banking Group plc (direct/indirect interests) 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 2/11/2009 6. Date on which issuer notified: 4/11/2009 7. Threshold(s) that is/are crossed or reached: Direct / Indirect holdings remain above 5% 8. Notified details: A: Voting rights attached to shares
possible using the ISIN CODE
ISIN GB00B01DW905 Resulting situation after the triggering transaction
possible using the ISIN CODE
ISIN GB00B01DW905 B: Financial Instruments Resulting situation after the triggering transaction
Total (A+B) Number of voting rights % of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
As question 4 Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: Notification using the total voting rights figure of 62,569,593 14. Contact name: Charlotte Parmenter 15. Contact telephone number: 01245-453643 This information is provided by RNS The company news service from the London Stock Exchange END
HOLUSONRKKRARAA More |
||
| 02-11-09 | RNS |
|
|
RNS Number : 8040B e2v technologies PLC 02 November 2009 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCE HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES. e2v technologies plc (the "Company")
PUBLICATION OF PROSPECTUS 2 November 2009 The Company announces that a prospectus dated today (the "Prospectus") relating to the proposed Firm Placing of 31,428,571 Firm Placed Shares at 70 pence per Firm Placed Share and 9 for 7 Rights Issue of 120,854,782 New Shares at 28 pence per share, which includes a notice of a general meeting, has been approved by the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at 25 The North Colonnade, Canary Wharf, London E14 5HS. Copies of the Prospectus will be posted to shareholders tomorrow and will also be available from tomorrow on the Company's website (www.e2v.com). The Prospectus can also be inspected from tomorrow at the offices of the Company at 106 Waterhouse Lane, Chelmsford Essex CM1 2QU and at the offices of Macfarlanes LLP at 20 Cursitor Street, London EC4A 1LT, during normal business hours on any weekday (except Saturdays, Sundays and Bank Holidays). Terms defined in the Prospectus have the same meanings in this announcement. Contacts For further information, please contact:
Keith Attwood, Chief Executive Charles Hindson, Group Finance Director THIS ANNOUNCEMENT SHALL NOT CONSTITUTE, OR FORM PART OF, AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES, NOR SHALL THERE BE ANY SALE OR PURCHASE OF SECURITIES IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION. THE AVAILABILITY OF THE FIRM PLACING AND THE RIGHTS ISSUE TO PERSONS NOT RESIDENT IN THE UNITED KINGDOM MAY BE AFFECTED BY THE LAWS OF THE RELEVANT JURISDICTIONS. SUCH PERSONS SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE REQUIREMENTS. This announcement is not for publication, distribution or release to persons in the United States, Australia, Canada, Japan, New Zealand, South Africa or Switzerland and should not be distributed, forwarded to or transmitted in or into any jurisdiction where to do so might constitute a violation of local securities laws or regulations. The securities discussed herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "US Securities Act") and may not be offered, sold, resold, taken up, exercised, renounced, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. No public offering of the securities referred to herein is being made in the United States. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. This information is provided by RNS The company news service from the London Stock Exchange END
PDIQLLFBKFBZFBL More |
||
| 02-11-09 | RNS |
|
|
RNS Number : 7932B e2v technologies PLC 02 November 2009 e2v technologies plc 02 November 2009 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: e2v technologies plc 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (X) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: Schroders plc 4. Full name of shareholder(s) (if different from 3.) : 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 30/10/2009 6. Date on which issuer notified: 2/11/2009 7. Threshold(s) that is/are crossed or reached: 5% 8. Notified details: A: Voting rights attached to shares
possible using the ISIN CODE
ISIN GB00B01DW905 Resulting situation after the triggering transaction
possible using the ISIN CODE
ISIN GB00B01DW905 B: Financial Instruments Resulting situation after the triggering transaction
Total (A+B) Number of voting rights % of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
America Ltd Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: 14. Contact name: Charlotte Parmenter 15. Contact telephone number: 01245-453643 This information is provided by RNS The company news service from the London Stock Exchange END
HOLUUOVRKNRARAA More |
||
| 29-10-09 | RNS |
|
|
RNS Number : 6292B e2v technologies PLC 29 October 2009 A second and final Price Monitoring Extension has been activated in this security. The closing auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still execute more than a pre-determined percentage above or below the price of the previous automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction call execution which will set today's closing price. The applicable percentage is set by reference to a security's TradElect sector. This is set out in the Sector Breakdown tab of the TradElect Parameters document at www.londonstockexchange.com/en-gb/products/membershiptrading/tradingservices</f ipP> This information is provided by RNS The company news service from the London Stock Exchange END
APMPUGUCUUPBGQB More |
||
| 29-10-09 | RNS |
|
|
RNS Number : 6266B e2v technologies PLC 29 October 2009 Today's closing auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security during the initial auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the last automated execution today. The applicable percentage is set by reference to a security's TradElect sector. This is set out in the Sector Breakdown tab of the TradElect Parameters document at www.londonstockexchange.com/en-gb/products/membershiptrading/tradingservices</f ipP> This information is provided by RNS The company news service from the London Stock Exchange END
PMEBLBDGUXDGGCC More |
||
| 29-10-09 | RNS |
|
This news article is displayed preformatted as it may contain results tables
RNS Number : 5677B
e2v technologies PLC
29 October 2009
e2v technologies plc
Interim results for six months to 30 September 2009
e2v technologies plc, a leading developer and manufacturer of high-technology electronic components and sub-systems to the medical & science, aerospace & defence, and commercial & industrial sectors, announces its interim results for the six months ended 30 September 2009:
Highlights 6 months ended 6 months ended Year ended
30 September 2009 30 September 2008 31 March 2009
£ million £ million £ million
Revenue 96.2 107.0 233.2
Adjusted* operating profit 3.6 11.6 27.4
Adjusted* profit before tax 1.6 8.5 20.4
Profit/(loss) before tax 2.6 3.1 (28.4)
Profit/(loss) after taxation 2.7 1.7 (21.3)
Total shareholders' equity 57.4 74.3 53.7
Net borrowings (excluding 105.2 88.0 137.3
capitalised borrowing costs)
Earnings/(loss) per share - 4.28p 2.74p (34.42)p
basic
Adjusted* earnings per share - 3.12p 10.32p 30.20p
basic
* Like for like sales down 26%, excluding QP and exchange rate movements
* Management actions to reduce and rephase costs secured £3.6m of adjusted* operating profit
* QP acquisition contributed £7.6m sales, and adjusted* operating profit of £2.9m
* Cash generated from operations of £22.1m (2008: £18.3m)
* Net borrowings reduced by £32.1m in last six months
* Charles Hindson appointed Group FD in May 2009, Chris Geoghegan became Chairman on 1 October 2009
* Potential accelerated restructuring programme announced today - approximately £33m of one-off costs to deliver approximate annualised savings of £26m
* £55.8m equity raising by firm placing and rights issue launched today with new 3 year banking facility, primarily to reduce indebtedness
Commenting on the results, Keith Attwood, Chief Executive said:
"The rapid decline in demand experienced through the latter part of 2008/09 has continued during the first half of 2009/10.
As a consequence of management's continuing focus on costs and cash along with significant support from the workforce in general, we managed to deliver a small adjusted* profit before tax and substantially reduce our net borrowings.
Looking forward, whilst some uncertainty remains, we now believe that our markets appear to be stabilising, and consequently, have started consultations on a potential accelerated restructuring programme, to better match our capacity to meet anticipated demand.
In addition, we have announced today a fully underwritten equity raising of £55.8m supported by a new banking facility. This will significantly reduce our indebtedness and provide the financial flexibility to support the potential restructuring of the cost base over the next 18 months."
*Adjusted profit is before amortisation of acquired intangibles, impairment charges, business improvement programme costs and fair value losses and gains on financial instruments and exchange gains on re-denomination of borrowings. Adjusted earnings is adjusted profit less tax impacts where applicable.
Further enquiries:
e2v technologies plc
Keith Attwood, Chief Executive Tel: 01245 493 493
Charles Hindson, Group Finance Director
Website: www.e2v.com
Financial Dynamics
Susanne Yule/Sophie Kernon Tel: 020 7269 7291
Review of the half year
OVERVIEW
The results for the first half of the financial year ending 31 March 2010 reflected the significant reduction in demand experienced by the Group since December 2008.
Reported sales decreased by 10% in the first half to £96.2m (2008: £107.0m). The acquisition of QP provided £7.6m of additional revenue and the strengthening of the Euro and US dollar also increased reported sales by 7.8% but the like for like sales declined 26% to £79.2m (2008: £107.0m). Adjusted* operating profit was £3.6m (2008: £11.6m) of which QP contributed £2.9m. Reported profit before tax of £2.6m was 16% lower than the prior period, with adjusted* profit before tax down 81.0% to £1.6m (2008: £8.5m).
Excluding the impact of the QP acquisition, sales fell in each of the Group's market sectors: aerospace and defence by 4%, medical and science by 21% and commercial and industrial by 29%. The major decline was experienced in Europe and North America.
Gross profit fell by 25.3% to £26.6m (2008: £35.6m) due in part to sales reducing more quickly that the relatively fixed operating cost base. A temporary period of short time working introduced in the UK and USA, along with an extended summer shutdown of the facility in France, achieved £2.0m of savings in the second quarter of the current financial year.
Research and development expenses (R&D) were down by 12.9% to £6.1m (2008: £7.0m) despite the inclusion of £0.7m for expenditure at QP. This includes the benefit of management action to rephase £0.8m into the second half of this financial year.
A range of additional overhead cost control actions were undertaken, with reductions in marketing, travel and general spend, achieving £1.0m of savings in the first half.
Selling and distribution expenses decreased by £0.2m to £7.9m (2008: £8.1m) net of the inclusion of £0.1m relating to QP, and were £1.5m lower than initially planned as a result of cost saving actions.
Administrative expenses, excluding amortisation of acquired intangibles, business improvement programme costs and fair value losses on foreign exchange contracts, increased by 2.3% to £9.0m (2008: £8.8m) primarily due to increased professional fees and provisions being partially offset by other savings from short time working.
Amortisation of acquired intangible assets increased to £4.5m (2008: £3.6m) reflecting the acquisition of QP. Fair value gains on foreign exchange contracts amounted to £2.7m (2008: loss £0.8m), and there were also gains arising on the fair value of interest rate swaps of £0.2m (2008: £0.4m). There were no additional provisions made for business improvement expenses (2008: £1.4m).
The adjusted* operating margin fell to 3.7% (2008: 10.8%). Finance costs fell by 38% to £2.1m (2008: £3.4m) despite higher borrowing levels due to lower bank base rates. Finance income included £0.2m (2008: £0.4m) of fair value gains on interest rate swaps together with the £2.6m exchange gains on re-denomination of borrowings arising from the transfer of the Group's Euro debt into Sterling which were excluded from adjusted* profits. The resulting adjusted* profit before tax fell by 81% to £1.6m (2008: £8.5m).
A further phase of the Group's established Business Improvement Programme, "Fit for the Future", was progressed during the first half. Costs incurred were within the provisions made during the financial year ended 31 March 2009 of £2.0m for the UK element of the programme. There was a net headcount reduction across the group of 133 between 31 March 2009 and 30 September 2009.
Profit before tax amounted to £2.6m (2008: £3.1m).
The underlying tax rate for the first half was 20% (2008:14.8%) due to a larger proportion of the Group's profits being generated in the USA.
Adjusted* earnings per share fell to 3.12p (2008: 10.32p) and reported earnings per share amounted to 4.28p (2008: 2.73p).
Operating cash flow improved in the first half to £22.1m (2008: £18.3m). This was largely due to improvements in working capital management. Tax receipts of £4.3m arose from R&D tax credit claims in France, the UK and the USA. After capital expenditure and capitalised R&D investment, additional fair value adjustments arising on the acquisition of QP and other financing costs, the overall net reduction in borrowings amounted to £23.4m. Exchange rate movements reduced net borrowings (excluding capitalisation of borrowing costs) by a further £8.7m. At 30 September 2009 the net borrowings amounted to £105.2m, a reduction of £32.1m since 31 March 2009.
Operating working capital (defined as inventories, trade and other receivables less trade and other payables) has been reduced by 27% since 31 March 2009 to £37.2m. Within operating working capital, inventories reduced by 18% to £34.9m.
Charles Hindson joined as Group Finance Director in May 2009 and on 25 September the Group announced the appointment of Christopher Geoghegan as Chairman of the Group, effective 1 October 2009.
The Company agreed an amended banking facility on 30 September 2009 as part of its preparations for raising additional equity and its associated new banking facility.
BUSINESS OVERVIEW
Electron Devices and Subsystems
Sales for Electron Devices and Subsystems ("EDS") reduced by 26.1% to £31.4m (2008: £42.5m). Excluding exchange rate movements, the decline was 30.4%. The economic downturn affected sales in all market sectors.
In the medical and science sector, radiotherapy OEMs continued to show relatively low demand for new systems. The new magnetron supply agreement with Tomotherapy was implemented in May, and OEMs continued de-stocking through the spring/summer, although there remained a solid spares business and demand was firmer in the second quarter.
In the aerospace and defence sector, demand for RF Subsytems was relatively low, reducing comparative turnover by 17%. Core activity was also down reflecting the profile of the order book at the start of the year.
Within the commercial and industrial sector, marine radar and satcom showed declines of around 17% and there were declines of around 40% in broadcast (with US digital transition completed) and industrial markets.
Adjusted* profit reduced by 52% to £5.0m (2008: £10.4m) due to the impact of lower sales of higher margin product lines. Reductions in warranty costs and cost reduction actions improved the operating margin and the adjusted* profit was within £0.3m of that achieved in the second half of 2008/09.
The order book at 30 September 2009 was higher at £66.6m (2008: £43.4m), reflecting the addition of multi-year orders for medical customers last year. The amount of the order book due for delivery in this financial year is £26.5m (2008: £28.0m).
Imaging
Sales for Imaging were down 16% to £24.6m (2008: £29.3m). Excluding exchange rate movements, sales were down 25% year on year.
Imaging has seen continued demand for space science programmes. Scientific imaging has shown modest revenue decline, with one major customer moving to second sourcing its supply. Dental imaging continued to decline for CCD based products and there was muted demand for new CMOS based products. Machine vision sales declined significantly in Europe, reflecting its late positioning in the capex cycle. There were, after the summer, signs of recovery in orders from Asian markets.
Adjusted* loss was £1.0m compared to a £0.7m profit in 2008, primarily due to lower dental and industrial sales compared with the fixed cost of running the wafer fab facility based in Grenoble. This resulted in the business being loss making in France, despite cost reduction activities and an extended summer shutdown.
The order book at 30 September 2009 was £35.4m (2008: £42.7m). £23.7m of the order book is due for delivery this financial year (2008: £23.4m).
Specialist Semiconductors
Sales for Specialist Semiconductors increased 19% to £24.9m (2008: £20.9m). Excluding contributions from QP, acquired last year, sales decreased by 17.4% and further, excluding exchange rate movements, like for like sales reduced 29.4%.
Compared with the six months to 30 September 2008, there was growth in aerospace and defence activities as this was positively impacted by QP, which showed sequential growth. In addition, de-stocking in the supply chain appeared to have slowed. Our high reliability assembly and test service based in Grenoble saw increased demand although commercial markets in the division have significantly declined.
Adjusted* profit increased by 3.7% to £2.8m (2008: £2.7m), reflecting QP's contribution of £2.9m of profit and other operations' breakeven performance.
The order book at 30 September 2009 was lower at £16.1m (2008: £17.2m), as order book visibility reduced through our customers moving towards smaller but more frequent orders, of which £12.8m (2008: £13.0m) is for delivery this financial year.
Sensors
Sales in Sensors increased by 7.7% to £15.3m (2008: £14.2m). Excluding exchange rate movements, growth was 2.4%.
The Microwave and High Speed Electronics business saw some growth in both the medical and defence sectors but challenging market conditions in the commercial sector have depressed overall sales by 5.5%. However, despite this, a variety of cost containment measures have led to an overall profit improvement of 16.3% against the same period last year for this product group.
In a generally weak automotive market, the MiCS air quality sensor product range showed 90% growth in the first half. This is predominantly attributable to growth in the Chinese market through customer adoption of air quality sensing technology on new automotive platforms.
Thermal Imaging cameras saw good underlying growth and an order from London Fire Brigade drove growth in the period up by 62.5%.
Gas Sensors had a large order in the first half of the previous year from China, which has not been repeated this year. Opportunities in the Asian market remain strong.
The Scientific Instruments business saw strong first half sales growth of 21% and continues on its growth curve through demand for the core Sirius SD product.
Following a strategic review of the Biosensors programme, this activity was closed in the period. Reported losses in the last full year were £1.0m and were £0.3m in the first half.
Adjusted* losses reduced £0.3m to £0.7m (2008: £1.0m) due to sales growth and the closure of the Biosensors programme.
The order book at 30 September 2009 was £15.5m (2008: £15.0m), of which £8.1m is for delivery in the financial year (2008: £7.1m).
Restructuring, rights issue and refocused strategy
We have announced today proposals for an extensive acceleration of the Group's "Fit for the Future" programme.
The potential restructuring programme, which will affect the Group's operations predominantly in France, but also in the UK, is subject to formal employee consultations which are anticipated to be completed by January 2010 in the UK and by April 2010 in France.
The potential French restructuring programme includes the Imaging business at Grenoble. Consultation is being undertaken on the options for the CCD wafer fab facility which may include its closure along with acceleration of the development of a "fabless" based CMOS Imaging business. The latter may complement the UK-based high-end CCD Imaging business. This consultation also includes options on the cost structure of the Specialist Semiconductor activities and support functions based in Grenoble. The potential restructuring of operations in the UK relates to the transfer to Chelmsford of the manufacturing activity of the Lincoln based microwave and high speed electronics (MHSE) business. Consideration is being given to other cost reduction activities as part of the continuing focus on cost and capacity management.
The overall cost of these steps to restructure the Group's operations is anticipated to be approximately £33m and would, on completion, provide annual savings of approximately £26m.
We have also today announced that the company proposes to raise £55.8m gross by the issue of new shares through a firm placing and rights issue. This will reduce the Group's debt profile, facilitate the potential "Fit for the Future" programme and provide a stronger financial base for the Group. The firm placing and rights issue are subject to approval by shareholders at a General Meeting scheduled to be held on 20 November 2009.
In addition,, on 29 October 2009, the Group entered into a new term and revolving facility of £105m, that becomes available on completion of the firm placing and rights issue, to refinance the existing facilities agreement. This facility will run for three years until 31 December 2012.
With these changes, our operational focus going forward will be on three core divisions:
* Electron Devices and Subsystems, where the development focus is on a range of RF Subsystems for existing customers and new customer funded applications
* Imaging with the increased focus for development on space and fabless CMOS products
* Specialist Semiconductors where the development focus is on End of Life management services in Europe and the use of the US SSA platform created within QP for bringing other Group products to the US market
along with continuing to review the options for disposal of other non core assets.
Principal Risks and Uncertainties for the Second Half
Along with uncertainties discussed under the Outlook below, the other principal risks and uncertainties for the Group in the second half of the financial year ending 30 March 2010 are that:
* The company requires shareholder approval to complete the fully underwritten equity capital finance raising so that the proposed restructuring of the group's balance sheet financing arrangements is completed.
* The potential "Fit for the Future" programme during both the periods of consultation and afterwards during its anticipated initial implementation may lead to disruption within the operations of the business and so have a negative impact on the Groups' financial performance.
Outlook
Like-for-like sales for the Group in the first half year declined by 26% in comparison to 2008 and, as yet, there are no firm indications that this decline has halted. However, whilst uncertain market conditions have made it difficult for the Group to pre-judge future developments, the Board believes that several of the markets in which the Group trades appear to be stabilising:
* In the science & medical markets, the dental business remains weak whilst the radiotherapy business has stabilised, with some signs of restocking
* In the aerospace & defence markets, demand remains strong in Imaging and is reasonably firm with respect to Specialist Semiconductors. Customer orders for delivery in the second half in Electron Devices and Subsystems have increased sequentially
* Trading in the commercial and industrial markets remains uncertain with some signs of recovery in Imaging and some parts of Electron Devices and Sub-systems
* The overall potential order pipeline for the Group, tracked by the sales function, has been stable during the course of the second quarter of this financial year.
The Board believes that full year sales for the Group will remain second half weighted, although results for this full financial year remain uncertain. The Board's expectations for the financial year are supported by an order book as at 30 September 2009 of £134m, of which £65m (excluding overdue orders) is for delivery in the second half of this financial year, compared to an order book of £118m of which £61m (excluding overdue orders) was for delivery in the second half of the previous financial year.
C Geoghegan K Attwood
Chairman Chief Executive Officer
*Adjusted profit is before amortisation of acquired intangibles, impairment charges, business improvement programme costs and fair value losses and gains on financial instruments and exchange gains on re-denomination of borrowings. Adjusted earnings is adjusted profit less tax impacts where applicable.
Directors' Responsibilities
We confirm that to the best of our knowledge:
* The condensed set of financial statements has been prepared in accordance with IAS 34;
* The interim management report includes a fair review of the information required by DTR 4.2.7R of the 'Disclosure and Transparency Rules', being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year: and
* The interim management report includes a fair review of the information required by DTR 4.2.8R of the 'Disclosure and Transparency Rules', being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during the period; and any changes in the related party transactions described in the last annual report that could do so.
The Directors of e2v technologies plc are listed in the Group's Annual Report for the year ended 31 March 2009.
K Attwood C Hindson
Chief Executive Officer Group Finance Director
29 October 2009 29 October 2009
Independent review report to e2v technologies plc
Introduction
We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2009 which comprises the Condensed consolidated income statement, Condensed consolidated statement of comprehensive income, Condensed consolidated statement of financial position, Condensed consolidated statement of cash flows, Condensed consolidated statement of changes in equity and the related notes 1 to 14. We have read the other information contained in the half yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
This report is made solely to the company in accordance with guidance contained in ISRE 2410 (UK and Ireland) "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our work, for this report, or for the conclusions we have formed.
Directors' Responsibilities
The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.
As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.
Our Responsibility
Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.
Scope of Review
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 September 2009 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.
Emphasis of matter
In forming our opinion on the half-yearly financial report, which is not qualified, we have considered the adequacy of the disclosures made in Note 1 of the half-yearly financial report concerning the Group's ability to continue as a going concern. These conditions indicate the existence of a material uncertainty which may cast significant doubt about the ability of the Group to continue as a going concern. The half-yearly financial report does not include any adjustments that would result if the Group were unable to continue as a going concern.
Ernst & Young LLP
Registered Auditor
Cambridge
29 October 2009
Condensed consolidated income statement
for the six months ended 30 September 2009
6 months ended 6 months ended Year
ended
30 September 2009 30 September 31 March
2008 2009
Note £000 £000 £000
Revenue 2 96,160 106,985 233,193
Cost of sales (69,580) (71,432) (154,223)
Gross profit 26,580 35,553 78,970
Research and development expenses (6,074) (6,997) (17,133)
Selling and distribution expenses (7,895) (8,143) (17,973)
Administrative expenses (10,809) (14,555) (63,399)
Operating profit/(loss) 1,802 5,858 (19,535)
Finance costs 3 (2,141) (3,366) (9,554)
Finance income 3 2,970 645 684
Adjusted profit before tax 2 1,556 8,517 20,389
Amortisation of acquired intangible assets (4,469) (3,609) (8,628)
Impairment of acquired intangible assets - - (26,127)
Impairment of plant and equipment - - (2,500)
Business improvement programme expenses - (1,388) (6,826)
Fair value gains/(losses) on foreign exchange contracts 2,694 (774) (2,894)
Fair value gains/(losses) on interest rate swaps 246 391 (1,819)
Realised exchange gains on re-denomination of Euro
borrowings 2,604 - -
Profit/(loss) before tax 2
2,631 3,137 (28,405)
Income tax credit/(expense) 4 25 (1,447) 7,106
Profit/(loss) for the period attributable to equity holders
of the parent 2,656 1,690 (21,299)
Earnings/(loss) per share - basic 5 4.28p 2.74 p (34.42)p
Earnings/(loss) per share - diluted 5 4.28p 2.73 p (34.37)p
Adjusted earnings per share - basic 5 3.12 p 10.32 p 30.20 p
Adjusted earnings per share - diluted 5 3.12 p 10.28 p 30.16 p
Condensed consolidated statement of comprehensive income
for the six months ended 30 September 2009
6 months ended 6 months ended Year
ended
30 September 2009 30 September 31 March
2008 2009
£000 £000 £000
Profit/(loss) for the period 2,656 1,690 (21,299)
(Loss) on cash flow hedges taken - (80) (80)
directly to equity
Exchange differences on 609 324 4,425
translation of foreign operations
Actuarial (loss)/gain on post (115) 158 (195)
employment employee benefits
Income tax relating to components - (5) (15)
of other comprehensive income
Other comprehensive income for the 494 397 4,135
period, net of tax
Total comprehensive income/(loss) 3,150 2,087 (17,164)
for the period, net of tax
Condensed consolidated statement of financial position
at 30 September 2009
30 September 30 September 31 March
2009 2008 2009
Note £000 £000 £000
Assets
Non-current assets
Property, plant and equipment 7 36,064 38,743 40,251
Goodwill 9 75,067 58,097 78,076
Other intangible assets 32,848 30,668 41,123
Deferred tax asset 3,613 2,966 5,860
147,592 130,474 165,310
Current assets
Inventories 34,861 41,955 42,433
Trade and other receivables 47,030 52,225 61,109
Derivative financial instruments - 443 -
Income tax recoverable 836 1,043 2,498
Cash and short-term deposits 10 19,396 6,546 6,373
102,123 102,212 112,413
Total assets 2 249,715 232,686 277,723
Liabilities
Current liabilities
Trade and other payables (44,663) (43,173) (52,567)
Derivative financial instruments (1,757) (1,226) (4,200)
Other financial liabilities (5,919) (8,094) (9,750)
Income tax payable (3,220) (946) (139)
Provisions (5,808) (5,325) (6,567)
(61,367) (58,764) (73,223)
Net current assets 40,756 43,448 39,190
Non-current liabilities
Derivative financial instruments (417) - (915)
Other financial liabilities (116,685) (85,464) (132,822)
Provisions - (350) -
Retirement benefit obligations 11 (3,403) (2,905) (3,355)
Deferred tax liability (10,493) (10,867) (13,729)
(130,998) (99,586) (150,821)
Total liabilities (192,365) (158,350) (224,044)
Net assets 57,350 74,336 53,679
Equity
Issued share capital 3,128 3,126 3,128
Share premium 41,780 41,750 41,780
Capital redemption reserve 274 274 274
Treasury shares reserve (5) (6) (5)
Foreign currency translation reserve 6,017 1,301 5,408
Retained earnings 6,156 27,891 3,094
Total equity attributable to equity holders
of 57,350 74,336 53,679
e2v technologies plc
Total equity and liabilities 249,715 232,686 277,723
Condensed consolidated statement of cash flows
for the six months ended 30 September 2009
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
Note £000 £000 £000
Cash flows from operating
activities
Profit/(loss) before tax 2,631 3,137 (28,405)
Net finance (income)/costs (829) 2,721 8,870
Operating profit/(loss) 1,802 5,858 (19,535)
Adjustments to reconcile to net
cash inflows from operating
activities:
Depreciation of property, plant and 7 5,333 4,512 10,204
equipment
Impairment of plant and equipment 7 - - 2,500
Amortisation of intangible assets 6,429 5,564 12,674
Impairment of intangible assets - - 26,127
Fair value (gains)/losses on (2,694) 774 2,894
foreign exchange contracts
Share based payment charge 521 387 625
Decrease in inventories 6,486 1,781 8,173
Decrease in trade and other 12,267 2,205 1,735
receivables
Decrease in trade and other (7,345) (3,253) (3,224)
payables
(Decrease)/increase in provisions (688) 520 875
Cash generated from operations 22,111 18,348 43,048
Income tax received/(paid) 4,320 (1,315) (1,297)
Net cash from operating activities 26,431 17,033 41,751
Cash flows from investing
activities
Proceeds from sale of property, 7 - 44 201
plant and equipment
Interest received 120 254 684
Purchases of property, plant and 7 (1,769) (4,043) (9,221)
equipment
Purchases of software (215) (588) (1,531)
Expenditure on product development (311) (1,214) (2,612)
Acquisition of subsidiary, net of 9 (634) - (41,059)
cash acquired
Net cash used in investing (2,809) (5,547) (53,538)
activities
Cash flows from financing
activities
Interest paid (1,717) (3,160) (7,338)
Proceeds from issue of shares, net - 649 681
of expenses
Dividends paid to equity holders of 6 - (3,237) (4,913)
the parent
Payment of finance lease - (13) (13)
obligations
Proceeds from borrowings 10 - - 38,152
Realised exchange gains on 3 2,604 - -
re-denomination of Euro borrowings
Transaction costs of bank (1,125) - (184)
facilities
Repayment of borrowings 10 (10,939) (5,097) (15,451)
Net cash (used in)/from financing (11,177) (10,858) 10,934
activities
Net increase/(decrease) in cash and 12,445 628 (853)
cash equivalents
Cash and cash equivalents at 6,373 5,806 5,806
beginning of period
Net foreign exchange difference 578 112 1,420
Cash and cash equivalents at end of 10 19,396 6,546 6,373
period
Condensed consolidated statement of changes in equity
for the six months ended 30 September 2009
Foreign
currency
translation
Issued Share Other Hedge reserve Retained Total
capital premium reserves reserve earnings equity
£000 £000 £000 £000 £000 £000 £000
1 April 2008 3,111 41,116 268 58 983 28,914 74,450
Hedge reserve and currency - - - (58) 318 - 260
translation movements
Profit for period - - - - - 1,827 1,827
Comprehensive (loss)/income - - - (58) 318 1,827 2,087
Issue of shares 15 634 - - - - 649
Share based payment charge - - - - - 387 387
Equity dividends paid - - - - - (3,237) (3,237)
30 September 2008 3,126 41,750 268 - 1,301 27,891 74,336
Currency translation movements - - - - 4,107 - 4,107
Loss for period - - - - - (23,358) (23,358)
Comprehensive income/(loss) - - - - 4,107 (23,358) (19,251)
Issue of shares 2 30 - - - - 32
Issue of shares by Employee
Benefit Trust on exercise of - - 1 - - (1) -
options
Share based payment charge - - - - - 238 238
Equity dividends paid - - - - - (1,676) (1,676)
31 March 2009 3,128 41,780 269 - 5,408 3,094 53,679
Currency translation movements - - - - 609 - 609
Profit for period - - - - - 2,541 2,541
Comprehensive income - - - - 609 2,541 3,150
Share based payment charge - - - - - 521 521
30 September 2009 3,128 41,780 269 - 6,017 6,156 57,350
Notes to the condensed interim financial statements
1. Basis of preparation and accounting policies
Basis of preparation
These condensed interim financial statements have been prepared in accordance with the accounting policies set out in the Group's 2009 Annual Report and were approved by the Board on 29 October 2009. The condensed interim financial statements for the six months ended 30 September 2009 have been prepared in accordance with IAS 34 'Interim Financial Reporting'. The condensed interim financial statements do not include all the information and disclosures that would be reported in a complete set of financial statements under IAS 1 'Presentation of Financial Statements' and therefore should be read in conjunction with the Group's annual financial statements as at 31 March 2009.
The financial information in these condensed interim financial statements does not constitute statutory financial statements as defined in Section 435 of the Companies Act 2006. The Group's 2009 Annual Report has been filed with the Registrar of Companies and, whilst the auditor's report on those financial statements was not qualified and did not contain a statement under section 237(2) or (3) of the Companies Act 1985, the auditor's report did include reference to the existence of a material uncertainty which may cast significant doubt on the Company's and Group's ability to continue as a going concern. The auditors drew attention to this matter by way of emphasis without qualifying their report.
The condensed interim financial statements are unaudited but have been formally reviewed by the auditor, Ernst & Young LLP, and their report to the Company is set out on page 7.
Going concern
The Group operates in a challenging business environment. Due to the lower levels of demand since December 2008 and the weakness of Sterling against both the Euro and the US dollar placing pressure on the banking covenants, specific short term actions were taken in the six months ended 30 September 2009. These actions included the reduction of costs, the restriction of capital expenditure, the close control of working capital, the conversion of debt denominated in Euros to Sterling in the period as well as entering into an amended facility agreement with its bankers. The result of these actions has enabled the Group to reduce net borrowings (excluding capitalised borrowing costs) from £137.3m at 31 March 2009 to £105.2m at 30 September 2009.
In order to provide a stronger financial base for the Group, the Board is implementing the following actions:
* The Group is now at the advanced stage of restructuring its financing by raising £55.8m gross of equity through a firm placing and rights issue, which will be used to reduce indebtedness. Although the rights issue is fully underwritten, on an irrevocable basis, its implementation requires approval by shareholders at the shareholders' meeting convened for 20 November 2009.
* The Group continues to operate in a challenging environment where, although trading conditions appear to be stabilising, activity is at a substantially reduced level. Therefore the Group is proposing to implement an extensive acceleration of its "Fit for the Future" programme that is anticipated to be implemented over an extended period.
* On 29 October 2009, the Group concluded a new banking facility which runs to 31 December 2012 that becomes available on completion of the firm placing and rights issue. Under this agreement the Group continues to be subject to covenant undertakings that require operating performance to meet certain financial covenants.
The Board has prepared detailed profit and cash flow forecasts through to 30 September 2011. In considering these profit and cash flow forecasts, as well as the refinancing, the potential reorganisation plan and the revised banking facilities the Board has carefully considered the assumptions and sensitivities. However, if the firm placing and rights issue is not approved by 30 November 2009, then the Group will be required to renegotiate the banking facilities as soon as is reasonably practical and therefore it may be unable to fund the potential extensive acceleration of the "Fit for the Future" programme.
The Board has concluded that obtaining shareholder approval for the firm placing and rights issue and completing the potential accelerated "Fit for the Future" programme, as anticipated, represents a material uncertainty at the date of this half-yearly report that casts significant doubt upon the Group's ability to continue as a going concern. Nevertheless, having considered these uncertainties the Board have reasonable expectations that shareholder approval for the firm placing and rights issue will be obtained and that the potential accelerated "Fit for the Future" programme will be completed in accordance with the anticipated plans and therefore believes the going concern basis of preparation of the half-yearly financial report continues to be appropriate. The half-yearly financial report does not include any adjustments that would result if the going concern basis of accounting were considered inappropriate.
Significant accounting policies
The accounting policies adopted in the preparation of the condensed interim financial statements are consistent with those followed in the preparation of the Group's annual financial statements for the year ended 31 March 2009, except for the adoption of new Standards and Interpretations, noted below. Adoption of these Standards and Interpretations did not have any effect on the financial position or performance of the Group.
* IFRS 2 'Share Based Payment' (revised) - The amendments clarify the accounting treatment of group cash-settled share based payment transactions. These amendments have no financial impact on the group.
* IFRS 8 'Operating Segments' - Requires disclosure of information about the Group's operating segments and replaces the requirements to determine primary (business) and secondary (geographical) reporting segments of the Group. The Group determined that the operating segments were the same as the business segments previously identified under IAS 14 'Segment Reporting'. Additional disclosures about each of these segments are shown in note 2 including revised comparative information.
* IAS 1 'Presentation of Financial Statements' (revised) - Introduced the 'Consolidated statement of comprehensive income' which presents all items of recognised income and expense either in one single statement, or in two linked statements. The Group has elected to present in two statements, the 'Consolidated income statement', formerly the Group income statement, and the 'Consolidated statement of comprehensive income', formerly the Group statement of recognised income and expense. In addition, it requires the reconciliation of movements in equity, previously disclosed in a note to the financial statements, to be presented as a primary statement, the 'Consolidated statement of changes in equity'.
The interim financial statements do not contain all the supplementary notes that would be reported in a complete set of financial statements under IAS 1 and are therefore referred to as 'condensed'.
2. Segmental information
In prior periods, in accordance with IAS 14 'Segment Reporting', the Group's segment information was reported by business segments and geographical segments. However, from 1 January 2009, in accordance with IFRS 8 'Operating Segments', the segmental information presented in the following tables is that which the chief operating decision maker (CODM) uses internally in evaluating the performance of operating segments and allocating resources to those segments.
The Group's operating segments are aggregated into four operating divisions, in line with the Group's divisional structure. These are the reportable segments, as follows:
Electron devices and sub-systems
High performance electron devices and sub-systems for applications including defence electronic countermeasures; radiotherapy cancer treatment machines; radar systems; satellite communication amplifiers; digital television transmitters and industrial heating.
Imaging devices
Advanced CCD and CMOS imaging sensors and cameras for applications including space, science and life science imaging; industrial process control; intra-oral and panoramic dental x-ray systems; military surveillance and automotive imaging.
Specialist semiconductors
Specialist semiconductors including logic, memory and microprocessors for applications including high reliability microprocessor requirements; mission-critical avionics and defence programs; high speed data conversion and sensor data acquisition utilising mixed signal applications specific devices.
Sensors
Sensors for a wide range of professional sensing products for applications including environmental safety; x-ray spectroscopy; automotive alarm and security systems; microwave radar and safety and arming devices and fire, rescue and security thermal imaging.
In addition to the reportable segments, also reported is:
Centre - corporate
Costs directly associated with the management of the Group's public quotation and other related costs arising for the corporate management of the group along with financing related activities.
Electron
devices and Imaging Specialist Centre -corporate Total
sub-systems devices semiconductors operations
Sensors
6 months ended 30 September 2009 £000 £000 £000 £000 £000 £000
Revenue
Revenue from external customers 31,380 24,574 24,923 15,283 - 96,160
Segment result
Adjusted segment profit/(loss) 5,016 (1,034) 2,838 (699) - 6,121
Unallocated expenses (1,944) (1,944)
Exchange differences - - - - (600) (600)
Net finance costs - - - - (2,021) (2,021)
Adjusted profit/(loss) before tax
5,016 (1,034) 2,838 (699) (4,565) 1,556
Amortisation of acquired intangible assets (4,469)
Fair value gains on foreign exchange
contracts 2,694
Fair value gains on interest rate swaps 246
Exchange gains on translation of
borrowings 2,604
Profit before tax 2,631
Tax credit 25
Profit for period 2,656
Adjusted profit before tax 1,556
Finance costs 2,141
Bank interest (Note 3) (120)
Adjusted operating profit 3,577
Total assets 17,569 21,747 98,675 18,730 92,994 249,715
Electron
devices and Imaging Specialist Centre -corporate Total
sub-systems devices semiconductors operations
Sensors
6 months ended 30 September £000 £000 £000 £000 £000 £000
2008
Revenue
Revenue from external 42,530 29,282 20,937 14,236 - 106,985
customers
Segment result
Adjusted segment profit/(loss) 10,403 689 2,653 (976) - 12,769
Unallocated expenses (1,213) (1,213)
Exchange differences - - - - 73 73
Net finance costs - - - - (3,112) (3,112)
Adjusted segment profit/(loss)
before exceptional items and 10,403 689 2,653 (976) (4,252) 8,517
tax
Amortisation of acquired (3,609)
intangible assets
Business improvement programme (1,388)
costs
Fair value losses on foreign
exchange (774)
contracts
Fair value gains on interest 391
rate swaps
Profit before tax 3,137
Tax charge (1,447)
Profit for period 1,690
Adjusted profit before tax
8,517
Finance costs 3,366
Bank interest (Note 3) (254)
Adjusted operating profit 11,629
Total assets 25,036 53,153 48,116 20,778 85,603 232,686
Electron
devices and Imaging Specialist Centre -corporate Total
sub-systems devices semiconductors operations
Sensors
Year ended 31 March 2009 £000 £000 £000 £000 £000 £000
Revenue
Revenue from external 83,739 65,224 53,323 30,907 - 233,193
customers
Segment result
Adjusted segment profit/(loss) 15,686 4,292 13,074 (1,596) - 31,456
Unallocated expenses - - - - (2,349) (2,349)
Exchange differences - - - - (1,667) (1,667)
Net finance costs - - - - (7,051) (7,051)
Adjusted profit/(loss) before
tax 15,686 4,292 13,074 (1,596) (11,067) 20,389
Amortisation of acquired (8,628)
intangible assets
Impairment of acquired (26,127)
intangible assets
Impairment of plant and (2,500)
equipment
Business improvement programme (6,826)
costs
Fair value losses on foreign
exchange (2,894)
Contracts
Fair value losses on interest (1,819)
rate swaps
Loss before tax (28,405)
Tax credit 7,106
Loss for period (21,299)
Adjusted profit before tax
20,389
Bank loan interest (Note 3) 7,323
Amortisation of debt issue 412
costs (Note 3)
Finance income (684)
Adjusted operating profit 27,440
Total assets 21,421 27,667 111,493 19,909 97,233 277,723
Revenue by geographic location
United
Kingdom Europe North America Asia Pacific Other Total
£000 £000 £000 £000 £000 £000
Revenue from external
customers
6 months ended 30 September 20,061 31,245 32,408 11,332 1,114 96,160
2009
6 months ended 30 September 20,229 39,505 35,514 10,026 1,711 106,985
2008
Year ended 31 March 2009 44,409 83,639 79,953 22,150 3,042 233,193
The Group operates in various locations around the world. The Group's country of domicile is the United Kingdom.
Revenue by location is based on the country the Group's customer is located in.
Non-current assets by location
(excluding deferred tax asset)
United
Kingdom Europe North America Asia Pacific Other Total
£000 £000 £000 £000 £000 £000
Non-current assets
(excluding deferred tax asset)
6 months ended 30 September 39,489 66,828 37,621 41 - 143,979
2009
6 months ended 30 September 47,703 79,425 320 60 - 127,508
2008
Year ended 31 March 2009 40,590 75,745 43,052 63 - 159,450
Non-current assets are allocated to the country of operation, based on the location of the statutory entity that owns the assets.
Total assets by location
United
Kingdom Europe North America Asia Pacific Other Total
£000 £000 £000 £000 £000 £000
Total assets
6 months ended 30 September 93,592 101,422 54,505 196 - 249,715
2009
6 months ended 30 September 102,092 115,985 14,382 227 - 232,686
2008
Year ended 31 March 2009 92,410 117,477 67,638 198 - 277,723
Total assets by location is additional information to that required for compliance with IFRS8.
3. Finance costs and finance income
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Finance costs
Bank loan interest 1,913 3,182 7,323
Amortisation of debt issue costs 228 184 412
Fair value adjustments to interest rate - - 1,819
swaps
2,141 3,366 9,554
Finance income
Bank interest 120 254 684
Fair value adjustments to interest rate 246 391 -
swaps
Realised exchange gains on 2,604 - -
re-denomination of Euro borrowings
2,970 645 684
4. Income tax
The tax charge for the period has been calculated on the basis of the Directors' best estimate of the underlying annual effective tax rate for the year of 20.0% (2008: 14.8%). The increase in the rate is due to the increase in the proportion of profits generated in the USA compared to the prior year.
The 2008 rate of 14.8% was before taking account of a one-off deferred tax charge in the period of £983,000 in respect of an increase in the UK deferred tax liability arising on the abolition of Industrial Buildings Allowances. The impact of this change was to increase the tax rate for the six months ended 30 September 2008 to 46.1%.
5. Earnings per share
The calculated basic and diluted earnings per share are based on the following:
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Profit/(loss) for the period 2,656 1,690 (21,299)
Adjusted earnings per share is arrived at using the following earnings and share numbers:
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Profit/(loss) for the period 2,656 1,690 (21,299)
Amortisation of acquired intangible 4,469 3,609 8,628
assets
Impairment of acquired intangible - - 26,127
assets
Impairment of plant and equipment - - 2,500
Business improvement programme costs - 1,388 6,826
Fair value (gains)/losses on financial (2,940) 383 4,713
instruments
Exchange gains on re-denomination of (2,604) - -
borrowings
Impact of abolition of Industrial - 983 983
Buildings Allowances
Tax impact of the above 357 (1,688) (9,793)
1,938 6,365 18,685
Weighted average number of ordinary No. 000 No. 000 No. 000
shares
For basic and adjusted earnings per 62,051 61,694 61,871
share
Effect of dilution:
Share options - 233 90
For diluted earnings per share 62,051 61,927 61,961
The adjusted earnings per share is considered to more appropriately reflect the underlying performance of the business. This reflects that the costs highlighted above are expected to be either non-recurring or not comparable between periods.
6. Dividends
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Interim dividend for 2009: 2.70p - - 1,679
Final dividend for 2009: nil (2008: - 3,237 3,234
5.25p) per share
- 3,237 4,913
The number of shares owned by the Employee Benefit Trust is 518,856 (518,856 at 30 September 2008 and 31 March 2009). The Employee Benefit Trust has waived its right to receive dividends. No final dividend for the year ended 31 March 2009 (2008: 5.25p) was proposed for shareholders approval at the Annual General Meeting and no interim dividend has been declared to date for the year ended 31 March 2010 (2008: 2.70p).
7. Property, plant and equipment
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Opening net book value 40,251 40,191 40,191
Additions 1,769 4,043 9,221
Acquisition of subsidiary - - 988
Impairments - - (2,500)
Disposals - (44) (201)
Depreciation (5,333) (4,512) (10,204)
Exchange difference (623) (935) 2,756
Closing net book value 36,064 38,743 40,251
8. Capital commitments
At 30 September 2009, the Group had capital commitments of £1,463,000 (30 September 2008: £2,864,000; 31 March 2009 £2,035,000) principally relating to the acquisition of new plant and machinery.
9. Goodwill
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Opening net book value 78,076 58,416 58,416
Acquisition of subsidiary (see note) 634 - 26,027
Impairments - - (19,171)
Exchange adjustment (3,643) (319) 12,804
Closing net book value 75,067 58,097 78,076
The acquisition costs in the six months arise due to a restatement of the fair value on acquisition of QP Semiconductor Inc. in 2008/09.
10. Net borrowings
6 months 6 months Year
ended ended ended
30 September 30 September 31 March
2009 2008 2009
£000 £000 £000
Cash at beginning of period 6,373 5,806 5,806
Loans at beginning of period (143,664) (100,217) (100,217)
Net borrowings at beginning of period (137,291) (94,411) (94,411)
Increase/(decrease) in cash 12,445 628 (853)
Proceeds from borrowings - - (38,152)
Repayment of borrowings 10,939 5,097 15,451
Exchange differences - cash 578 112 1,420
Exchange differences - loans 8,161 534 (20,746)
Total movement in net borrowings 32,123 6,371 (42,880)
Cash at end of period 19,396 6,546 6,373
Loans at end of period (124,564) (94,586) (143,664)
Net borrowings at end of period (105,168) (88,040) (137,291)
Net borrowings exclude capitalised borrowings costs which amounted to £1,960,000 at 30 September 2009, £1,029,000 at 30 September 2008 and £1,092,000 at 31 March 2009.
11. Retirement benefit obligations
Defined contribution plans
The Group has defined contribution plans in the UK and North America, covering substantially all of its employees, which require contributions to be made to a separately administered fund. The Group contributes to state schemes for European activities. Such schemes are defined contribution schemes and there is no Group exposure to any scheme liabilities.
Retirement benefit plan
In addition to the state pension scheme, the French overseas subsidiary based in Grenoble has a defined benefit retirement plan where there is an obligation to provide termination allowances and benefits called 'Medailles du Travail'. This is an unfunded plan and the actuarial liability has been calculated at 30 September 2009 by a qualified actuary using the projected unit credit method. The cost of providing these benefits is charged to the income statement in the period in which those benefits have been earned by the employees. Actuarial gains and losses are recognised in full in the period in which they arise and are recognised in the statement of comprehensive income.
12. Share based payments
Full details regarding share based award schemes operated by the Group are disclosed in the Group's annual financial statements as at 31 March 2009. During the period, under the 'Long Term Incentive Plan' 179,200 awards lapsed and 540,600 awards were granted, under the 'Executive Share Option Plan'149,500 awards lapsed and there were no awards granted. A new 'Sharesave Scheme' was launched on 17 July 2009, with a scheme contract commencement date of 1 November 2009, at 57p per share.
13. Related party disclosure
Transactions between Group subsidiaries have been eliminated on consolidation. A list of subsidiaries can be found in the notes to e2v technologies plc, the parent company, financial statements in the Group's 2009 Annual Report
14. Events after the end of the reporting period
Since the end of the reporting period the Group has announced:
* The potential accelerated restructuring programme, whose cost is anticipated to be approximately £33m and is anticipated to realise annual cost savings of approximately £26m after completion.
* A firm placing and rights issue to raise £55.8m of equity in order to reduce borrowings and strengthen the Group's balance sheet. This is subject to shareholder approval.
* A new three year banking facility that becomes available on completion of the firm placing and rights issue.
NOTES FOR EDITORS
e2v
e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets.
e2v is organised into four divisions:
* High performance electron devices and subsystems for applications including defence electronic countermeasures, radiotherapy cancer treatment, radar systems, industrial heating, satellite communications amplifiers and digital television transmitters.
* Advanced CCD and CMOS imaging sensors and cameras for applications including space, science and life science imaging, industrial process control, intra-oral and panoramic dental X-ray systems, military surveillance and automotive imaging.
* Specialist Semiconductors - including logic, memory and microprocessors for high reliability microprocessor and MRAM requirements, in partnership with Freescale Semiconductor and Everspin, mission-critical avionics and defence programs requiring high reliability integrated circuits, high speed data converters and sensor data acquisition utilising mixed signal application specific devices.
* A range of professional sensing products for applications including environmental safety, x-ray spectroscopy, automotive alarm and security systems, microwave radar and safety and arming devices, fire rescue and security thermal imaging.
For the year ended 31 March 2009, e2v achieved sales of £233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base.
The Company is headquartered in the United Kingdom and has approximately 1700 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers.
Further information is available from www.e2v.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR EKLBLKBBFFBX
More |
||
| 29-10-09 | RNS |
|
|
RNS Number : 5687B e2v technologies PLC 29 October 2009 29 October 2009 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR THEIR RESPECTIVE TERRITORIES. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCED HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES. This announcement has been issued by and is the sole responsibility of e2v. It shall not constitute, or form part of, any offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale or purchase of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The availability of the Firm Placing and the Rights Issue to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any applicable requirements. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights, and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. Any person receiving this announcement is advised to exercise caution in relation to the Firm Placing and Rights Issue. If in any doubt about any of the contents of this announcement, independent professional advice should be obtained.
E2V TECHNOLOGIES PLC
PROPOSED FIRM PLACING AND RIGHTS ISSUE
AND
REFINANCING OF THE GROUP'S LENDING FACILITIES The Board of Directors of e2v technologies plc ("e2v" or the "Company" or the "Group") today announces a fully underwritten Firm Placing and Rights Issue to raise gross proceeds of approximately £56 million. The Firm Placing and the Rights Issue are subject to approval by Shareholders at a General Meeting. A prospectus containing a notice of general meeting will be posted to shareholders shortly. In conjunction with the Firm Placing and the Rights Issue, the Board today announces that it has reached agreement on new committed lending facilities and also outlines the potential extensive acceleration of the "Fit for the Future" restructuring programme. In a separate announcement e2v has today announced its interim results for the six months ended 30 September 2009. Highlights of the capital raising and new debt facilities
Overview of management actions and restructuring programme e2v is today announcing proposals for an extensive acceleration of the Group's "Fit for the Future" programme. The potential restructuring programme, which will affect the Group's operations in France and the UK, is subject to formal employee consultations which are anticipated to be completed by April 2010. The potential French restructuring programme includes the Imaging business at Grenoble. Consultation is being undertaken on the options for the CCD wafer fab facility which may include its closure along with acceleration of the development of a "fabless" based CMOS Imaging business. The latter may complement the UK-based high-end CCD Imaging business. This consultation also includes options on the cost structure of the Specialist Semiconductor activities and support functions based in Grenoble. The potential restructuring of operations in the UK relates to the transfer to Chelmsford of the manufacturing activity of the Lincoln based microwave and high speed electronics (MHSE) business. Consideration is being given to other cost reduction activities as part of the continuing focus on cost and capacity management. The overall cost of these steps to restructure the Group's operations is anticipated to be approximately £33m and would, on completion, provide annual savings of approximately £26m. e2v has also today announced that the Company proposes to raise £55.8m gross by the issue of new shares through a firm placing and rights issue. This will reduce the Group's debt profile, facilitate the potential "Fit for the Future" programme and provide a stronger financial base for the Group. The firm placing and rights issue are subject to approval by shareholders at a General Meeting scheduled to be held on 20 November 2009. In addition, on 29 October 2009, the Group entered into a new term and revolving facility of £105m, that becomes available on completion of the firm placing and rights issue, to refinance the existing facilities agreement. This facility will run for three years until 31 December 2012. With these changes, e2v's operational focus going forward will be on three core divisions:
along with continuing to review the options for disposal of other non core assets. Current trading and prospects
Expected timetable of principal events (1) Each of the times and dates in the table below is indicative only and may be subject to change.
2009
London Stock Exchange
Exchange
registration of renunciation of Provisional Allotment
Letters
Stock Exchange Notes: (1) The times and dates set out in the expected timetable of principal events above and mentioned throughout this announcement may be adjusted by the Company (in consultation with Rothschild and RBS Hoare Govett), in which event details of the new times and dates will be notified to the UKLA, the London Stock Exchange and, where appropriate, Qualifying Shareholders and Placees. References to times in this timetable are to London times unless otherwise stated. This summary should be read in conjunction with the full text of this announcement. A prospectus relating to the Firm Placing and the Rights Issue (the "Prospectus") is expected to be published shortly and will be available at the registered office of e2v at 106 Waterhouse Lane, Chelmsford, Essex CM1 2QU and on the Company's website, www.e2v.com. Rothschild is acting as Financial Adviser to the Company and Sponsor to the Firm Placing and the Rights Issue. RBS Hoare Govett is acting as Bookrunner and Underwriter. Contacts For further information, please contact:
ExecutiveCharles Hindson, Group Finance Director
HimsworthRoger HemmingJohn Byrne
Corporate Broking:John MacGowanAlexander
GartonSyndication:Lee Morton
Shareholder enquiries If you have any queries about the Firm Placing and the Rights Issue, please telephone the Shareholder Helpline on 0871 384 2927 or, if you are calling from outside the United Kingdom, +44 121 415 0268. This helpline is available between 8.30 a.m. to 5.30 p.m. on any Business Day.
Calls to the 0871 384 2927 number are charged 8p per minute (including VAT) from a BT landline. Other service providers' costs may vary. Calls to the +44 121 415 0268 number from outside the UK are charged at applicable international rates. Different charges may apply to calls made from mobile telephones and calls may be recorded and monitored randomly for security and training purposes. Please note that for legal reasons, the Shareholder Helpline is only able to provide you with information contained in this announcement and, when published, the Prospectus and information relating to e2v's register of members and is unable to give advice on the merits of the Firm Placing and the Rights Issue or provide legal, financial, tax or investment advice. If you are in any doubt as to the action you should take, you should immediately seek your own financial advice from your stockbroker, bank manager, solicitor, accountant, fund manager or other independent financial adviser authorised under FSMA or, if you are outside the UK, by another appropriately authorised independent financial adviser.
1. Introduction The Board of e2v today announces that e2v is proposing to raise gross proceeds of approximately £56 million by way of the Firm Placing and the Rights Issue. The Firm Placing, comprising in aggregate 31,428,571 Firm Placed Shares (representing approximately 50 per cent. of the Company's existing issued share capital) will raise £22 million. The Firm Placing Price represents a 1 per cent. premium to the closing price of 69 pence per Share on 28 October 2009 (being the last trading day prior to the date of the announcement of the Firm Placing and the Rights Issue). The Firm Placing is subject to Shareholder approval. Pursuant to the Rights Issue it is proposed that 120,854,782 New Shares be issued by way of rights to Qualifying Shareholders and Placees at 28 pence per New Share. The Rights Issue is expected to raise gross proceeds of £34 million. The Rights Issue Price represents:
The Firm Placing and the Rights Issue have been fully underwritten by RBS Hoare Govett and are conditional, inter alia, upon the passing of the Resolutions by Shareholders at the General Meeting. Rothschild is acting as Financial Adviser to e2v and as Sponsor to the Firm Placing and the Rights Issue. In addition, also announced today, the Group entered into a new term and revolving facility of £105 million to refinance the Existing Facilities Agreement. The New Lending Facilities will only refinance the Existing Lending Facilities if the Firm Placing and the Rights Issue complete and will be drawn down on 31 December 2009. In the event that the Firm Placing and the Rights Issue do not complete, the New Lending Facilities will not refinance the Existing Lending Facilities. 2. Background to the Firm Placing and Rights Issue e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for the aerospace & defence, commercial & industrial and medical & science markets. The Company has been quoted on the London Stock Exchange since 2004 and, since that time, the Company's sales have grown from £98m in the financial year ended 31 March 2004 to £233m in the 2008/2009 Financial Year. The Group specifically targets markets that exhibit long term growth, high barriers to entry, require a significant proportion of bespoke design and have a limited number of competitors. e2v does not seek to compete in commoditised markets. The Group's business strategy has four key elements:
Resulting from the Group's business strategy set out above, for over the last three financial years up until 31 March 2009, the Group's sales have increased by 107.7 per cent. (from £112.3m to £233.2m) and Adjusted profit before tax and net finance costs has increased by 83.9 per cent. (from £14.9m to £27.4m). This growth has predominantly been achieved through acquisitions. In addition, the Company has paid aggregate dividends of £13m in the three years to 31 March 2009. The Group has introduced 391 new products in the last 3 financial years which accounted for 26 per cent. of sales during the 2008/2009 Financial Year. e2v's sub-systems business activities account for 18.4 per cent. of sales in the 2008/2009 Financial Year. Between the end of the 2006/2007 Financial Year and the end of the 2008/2009 Financial Year, the Group reduced average net headcount after acquisitions across the Group by 5.2 per cent., increased operating profit per employee by 38.4 per cent. and improved operating cash flow by 62.6 per cent. However, the Group has not been immune to the deteriorating economic conditions over the last 12 months which have culminated in recession in many developed economies. In particular, the Group has, since December 2008, seen a progressive weakening in demand across some of its commercial & industrial market sectors and in its medical market sector. Additionally, during the first quarter of the current financial year, delayed programme phasing was noticeable within the US business of the specialist semiconductor division, and since then there have been deferrals in the award of certain defence contracts throughout the Group's geographic markets. Financial results for the 2009/2010 Half Year were as follows:
In addition, the Group has reduced its net borrowings by £32m since 31 March 2009, to £105m. Like for like sales for the 2009/2010 Half Year reduced by 26 per cent. when compared with the 2008/2009 Half Year. The Group's acquisition programme has been largely funded by debt and in currencies, predominantly the Euro and the US dollar, that matched the acquired asset base. The weakening of Sterling in the 12 months to 31 March 2009 against both the Euro and the US dollar had significant ramifications for the Company. Whilst exports from Europe, and particularly the UK, to the United States are now more competitively priced against products of the Group's US competitors, the Group's multi-currency borrowings had, when translated into Sterling for reporting and covenant testing purposes, significantly increased, contributing some £19.4m to the increase in the Group's net borrowings of £137.3m as at 31 March 2009. In the 2009/2010 Half Year there was a decrease in net borrowings of £8.7m as a result of exchange movements. 3. Current actions by management to improve profitability To minimise the impact of the difficult trading conditions in this challenging environment, the Directors have instigated additional specific measures in the 2009/2010 Half Year to control further the Group's cost:
In addition, to further preserve cash and reduce indebtedness:
Notwithstanding the early success of the actions described above, the prolonged challenging trading conditions continue to place pressure on the Group's sales, profits and cash flows. 4. The Restructuring Programme and planned actions by management to improve profitability Further changes to the Group's business are being proposed which would be expected to provide the increased flexibility and scaleability required to match effectively the Group's capacity to demand and to maximise opportunities when economic conditions improve. This is likely to be achieved through the potential extensive acceleration of the Group's established "Fit for the Future" restructuring programme, which the Directors' believe would significantly reduce the fixed cost base of the Group's business to ensure that the Group's business resources are consistent with the Directors' current view of future demand. In addition to the focus on cost reduction, the proposed restructuring programme is intended to streamline the Group's operations, optimising business processes such that the Group operates at improved efficiency levels, which the Directors anticipate will significantly enhance various customer and operational metrics, most notably customer satisfaction, inventory levels, on-time delivery, production lead times and product quality. Any restructuring programme, which would affect the Group's operations in France, and in the UK, would be subject to formal employee consultations, in compliance with applicable laws and regulations. In e2v's facility based in Grenoble, France, it is proposed that the business activities associated with the imaging devices division should be refocused around a fabless CMOS business model, which provides a complementary activity to the CCD focused UK imaging operations. It is also expected that that the Grenoble based activities associated with the specialist semiconductors division would be enhanced as a consequence of this programme. The Group had, for a number of months, recognised the need to reduce its overall imaging CCD fabrication capacity for the long term and had considered the gradual migration of its UK activities into its operations in Grenoble. However, following the rapid reduction in demand from the markets primarily served by the Grenoble facility, the potential closure of the imaging CCD fabrication facility based in Grenoble (subject to consultation with the French workers union) is considered by the Directors to be the optimum solution to rapidly reduce overall capacity at a lower cost and with the least technical and commercial risk. In addition, the Group is considering how to address surplus capacity requirements in its other operations, principally in the UK. The Lincoln based microwave and high speed electronics business was subject to a previously announced potential disposal programme. After lengthy discussions with potential buyers however, the Board is considering whether the transfer of the majority of the manufacturing facilities from Lincoln to other of the Group's sites would create more value for Shareholders than a sale at the price that was indicated by potential buyers. Further restructuring activity at the Chelmsford facility may also be considered in the future in addition to the creation of an engineering centre in Lincoln. Subject to compliance with the applicable consultation obligations, the overall cost of any restructuring programme (including redundancy, move and other closure costs), is estimated to be approximately £33m and would on completion provide annual savings of approximately £26m. As part of any restructuring programme, the Group may also consider introducing, for example, new working practices, incorporating flexible hours for appropriate staff. The Board believes this is likely to enable the Group to better match capacity to demand and therefore respond more rapidly to any potential upturn in customer demand. The Board believes that any restructuring programme would create a platform for the long-term strategic development of the Group to create value for Shareholders, and would support a medium term emphasis on growth, by the:
In addition, as part of the restructuring programme, the senior management team has already been reduced from 13 to 8, and strengthened by the appointment of Charles Hindson as Group Financial Director in May 2009 and Chris Geoghegan as Chairman on 1 October 2009. 5. Reasons for the Firm Placing and the Rights Issue Against this background, in addition to the measures already taken, e2v today announces the Firm Placing and the Rights Issue to raise gross proceeds of £56 million in order to reduce the Group's debt profile and provide a stronger financial base. Reducing the Group's debt profile The proceeds of the Firm Placing and the Rights Issue will be used to repay existing debt. The Group will, as required pursuant to the terms of the Existing Facilities Agreement and as a condition to the New Lending Facilities becoming available, use at least £30m of the net proceeds of the Firm Placing and the Rights Issue to reduce the amounts outstanding under the Existing Facilities Agreement (such amount to be held in a holding account between completion of the Firm Placing and the Rights Issue and payment of the £30m on 31 December 2009). The remaining net proceeds of £22 million (the "Additional Proceeds") will also be used to reduce net borrowings. Stronger financial base The Board believes this reduced level of indebtedness and increased headroom under the financial covenants in the Group's debt facilities following the reduction described above, should provide the Group with the appropriate financial flexibility to implement, and fund from anticipated operational cash flows, the potential acceleration of the "Fit for the Future" restructuring programme. It should also provide the Group with a stronger financial base, which should ensure that the Group maintains access to cost effective sources of funding and should give the Group a stronger credit standing. Moreover, the Board believes this stronger financial base means the Group should be able to respond to opportunities that may arise to accelerate growth either organically or, in due course, if the Directors consider it prudent to do so and with the consent of the Group's lending banks, through the addition of complementary businesses and technologies, particularly if attractive consolidation opportunities were to arise. The net proceeds of the Firm Placing and the Rights Issue will be used to repay existing debt and, consequently, the Directors believe that net borrowings, following receipt of proceeds from the Firm Placing and the Rights Issue, will be at an appropriate level taking into account the planned restructuring. The Directors expect that the Firm Placing and the Rights Issue should make a positive contribution to total earnings in the medium term as it will provide the Group with the financial resources and flexibility to enable the Group to continue to pursue the restructuring programme in a manner which the Directors believe will have a positive effect on earnings. However, the Directors expect that the increased number of Shares in issue following the Firm Placing and the Rights Issue will have a negative effect on the Company's earnings per Share for the same period. 6. New Lending Facilities Also announced by the Board today, the Group entered into new term and revolving facilities of £105 million (the "New Facilities Agreement") to refinance the Existing Lending Facilities. The New Lending Facilities can only be utilised if, amongst other things, the Firm Placing and the Rights Issue complete and will be drawn down on 31 December 2009. In the event that the Firm Placing and the Rights Issue does not complete, the New Lending Facilities will not refinance the Existing Lending Facilities. At least £30m from the proceeds of the Firm Placing and Rights Issue will be applied in reduction of amounts outstanding under the Existing Lending Facilities before the Existing Lending Facilities are refinanced by the New Lending Facilities. The principal terms of the New Facilities Agreement are:
The Directors believe that the New Lending Facilities will provide the Group with increased financial flexibility going forward, including by virtue of an extended maturity date for the New Lending Facilities and through the reduction of amounts outstanding under the facilities (as compared to under the Existing Facilities Agreement) which is to be made from the proceeds of the Firm Placing and the Rights Issue. 7. Dividends and dividend policy The Company did not pay a final dividend for the financial year ended 31 March 2009, nor did it pay an interim dividend for the period ended 30 September 2009. Pursuant to the terms of the Existing Facilities Agreement (and the New Facilities Agreement if and when it comes into effect), the Company has undertaken only to declare and pay dividends if certain covenant tests are met and no default exists under the facility agreement in force at the relevant time. The Board remains committed to pursuing a progressive dividend policy and, assuming the Company can meet the relevant tests in the Existing Facilities Agreement or the New Facilities Agreement (as the case may be), e2v will resume dividend payments once market conditions improve and the Directors believe it is prudent to do so. The level of future dividend payments will take into account the Company's underlying earnings, cash flows and capital investment plans, the requirement to maintain an appropriate level of dividend cover and the prevailing market outlook. 8. General meeting Notice of the General meeting will be made shortly upon publication of the prospectus in line with the indicative timetable in the summary of this announcement. All the Resolutions to be proposed at the General meeting are required in order to enable the Company to implement the Firm Placing, the Rights Issue and, accordingly, the Firm Placing, the Rights Issue are conditional on the Resolutions being passed. Appendix 9. TERMS AND CONDITIONS OF THE FIRM PLACING THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND. IMPORTANT INFORMATION ON THE PLACING FOR PLACEES ONLY. MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN ARE FOR INFORMATION PURPOSES ONLY AND ARE DIRECTED ONLY AT: (A) PERSONS IN RELEVANT MEMBER STATES WHO ARE QUALIFIED INVESTORS PURSUANT TO THE PROSPECTIVE DIRECTIVE (DIRECTIVE 2003/71/EC); AND (B) IN THE UNITED KINGDOM, QUALIFIED INVESTORS WHO ARE RELEVANT PERSONS PURSUANT TO FSMA (IN EACH CASE A "RELEVANT PERSON"). THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. THIS APPENDIX DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY.
Persons who are invited to and who choose to participate in the Placing, by making an oral or written offer to subscribe for Placing Shares (each, a "Placee"), will be deemed to have read and understood this Announcement, including this Appendix, in its entirety and to be making such offer on the terms and conditions contained herein, and to be providing the representations, warranties, acknowledgements, and undertakings contained in this Appendix. In particular, each such Placee represents, warrants and acknowledges that:
(a) it is a Relevant Person (as defined above) and undertakes that it will
(b) (i) it is a person whose ordinary activities involve it in acquiring,
(c) it is outside the United States of America (including its territories
(d) it is not (i) acquiring the Placing Shares for the account of a person
(e) it is not resident or domiciled in or a national of Australia, Canada,
This Appendix and the Announcement of which it forms part does not constitute, or form part of, any offer to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction in which such offer or solicitation is or may be unlawful including, without limitation, the United States and any of the Excluded Territories. This Announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States or any of the Excluded Territories, or any jurisdiction in which such publication or distribution is unlawful. No public offer of securities of the Company is being made in the United Kingdom, the United States or elsewhere. In particular, the Placing Shares referred to in this Appendix and the Announcement of which it forms part have not been and will not be registered under the Securities Act or any State of the United States, and may not be offered, sold or transferred, directly or indirectly in or into the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable State securities laws. The Placing Shares are being offered and sold outside the United States in accordance with Regulation S. The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any State securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this Announcement. Any representation to the contrary is a criminal offence in the United States. The distribution of this Appendix, the Announcement of which it forms part and the Placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or RBS Hoare Govett or NM Rothschild & Sons Limited, acting as sponsor in relation to the Placing and Rights Issue (together with RBS Hoare Govett the "Banks" and each a "Bank") or any of their respective affiliates that would permit an offer of the Placing Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company and the Banks to inform themselves about and to observe any such restrictions. The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with or registered by, the Australian Securities and Investments Commission, the Japanese Ministry of Finance, the New Zealand Securities Commission, the South African Reserve Bank or the Swiss Federal Banking Commission; and the Placing Shares have not been, nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of any of the Excluded Territories. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into the United States, or any of the Excluded Territories, or any other jurisdiction outside the United Kingdom. Each Placee, by participating in the Placing, agrees that it has neither received nor relied on any information, representation, warranty or statement made by or on behalf of either of the Banks or the Company other than publicly available information and neither the Banks nor the Company or any person acting on such person's behalf nor any of their affiliates has or shall have any liability for any Placee's decision to accept this invitation to participate in the Placing based on any other information, representation, warranty or statement. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of this Appendix or the Announcement of which it forms part should seek appropriate advice before taking any action. Details of the Placing Agreement and the Placing Shares The Banks have entered into a Firm Placing and Rights Issue Underwriting and Sponsor Agreement (the "Underwriting Agreement") with the Company under which RBS Hoare Govett has, on the terms and subject to the conditions set out therein and as agent for and on behalf of the Company, undertaken to use reasonable endeavours to procure subscribers for the Placing Shares at the Placing Price. Subject to the terms and conditions of the Underwriting Agreement, in the event that Placees cannot be procured for the entire amount of the Placing Shares or if a Placee has unconditionally agreed to subscribe for Placing Shares pursuant to its Placing Letter but fails to make to payment therefore, RBS Hoare Govett has agreed itself to subscribe for such Placing Shares at the Issue Price. The Placing Shares will, when issued and fully paid, be credited as fully paid and will rank pari passu in all respects with the existing issued ordinary shares in the capital of the Company ("Ordinary Shares") including the right to receive all dividends and other distributions declared, made or paid after the date of issue, including the right to participate in the Rights Issue in respect of the Placing Shares pursuant to the terms and conditions of the Rights Issue as set out in the Prospectus. By signing and returning the Letter of Confirmation a Placee undertakes and agrees, following the acquisition of Placing Shares in the amount of its Placing Participation, to take up in full the rights to Rights Issue Shares relating to its Placing Shares pursuant to the proposed Rights Issue on the terms and conditions set out in the Prospectus. Nil Paid Rights in respect of the relevant Rights Issue Shares will be distributed to the Placee's CREST account automatically through the CREST market claims mechanism. In this Appendix, unless the context otherwise requires, "Placee" means a person (including individuals, funds or others) by whom or on whose behalf a commitment to subscribe for Placing Shares has been given. Application for listing and admission to trading Application will be made to the Financial Services Authority (the "FSA") for admission of the Placing Shares to the Official List of the FSA (the "Official List") and to the London Stock Exchange plc for admission to trading of the Placing Shares on its market for listed securities (together, "Placing Admission"). It is expected that Placing Admission will become effective on 23 November 2009 and that dealings in the Placing Shares will commence at that time. RBS Hoare Govett will today commence the bookbuilding process in respect to the Placing (the "Bookbuild") to determine demand for participation in the Placing by Placees. This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. RBS Hoare Govett and the Company shall be entitled to effect the Placing by such alternative method to the Bookbuild as they may, in their absolute discretion, determine.
Participation in, and principal terms of, the Placing
bookrunner of the Company. 2 Unless RBS Hoare Govett, in its absolute discretion, agrees otherwise, participation in the Placing will be available only to persons who may lawfully be, and are, invited to participate by RBS Hoare Govett and who execute a placing letter prior to Placing Admission (the "Placing Letter"). RBS Hoare Govett and its affiliates are entitled to enter bids
in the Bookbuild as principal.
discretion agrees otherwise, Placees shall communicate their bid by telephone to their usual sales contact at RBS Hoare Govett (provided that they subsequently execute and return the Letter of Confirmation (as defined below) no later than 5 p.m. on 29 October 2009). Each bid should state the number of Placing Shares which the prospective Placee wishes to
subscribe for.
October 2009 but may be closed earlier or later at the discretion of RBS Hoare Govett. RBS Hoare Govett may, in agreement with the Company, accept bids that are received after the Bookbuild has closed. The Company and RBS Hoare Govett reserve the right to reduce or seek to increase the amount to be raised pursuant to the Placing, in their absolute
discretion.
Placing Letter in respect of such allocation will be sent to such Placee, by RBS Hoare Govett following the closing of the Bookbuild. RBS Hoare Govett reserves the right to reject or scale back bids from prospective Placees following consultation with the Company. Upon receipt of a letter of confirmation from a Placee by RBS Hoare Govett in the form set out in the schedule to the Placing Letter (a "Letter of Confirmation"), RBS Hoare Govett's oral confirmation to such Placee will constitute an irrevocable legally binding commitment upon such person (who will at that point become a Placee) in favour of each of RBS Hoare Govett and the Company, under which it agrees to subscribe for the number of Placing Shares set out in its Letter of Confirmation and allocated to it at the Placing Price on the terms and conditions set out in this Appendix and in accordance with the Company's Memorandum and Articles of Association. On
the second Business Day
the terms and subject to the conditions in this Announcement (including this Appendix) and, unless RBS Hoare Govett, in its absolute discretion, agrees otherwise, will be legally binding on the Placee on behalf of which it is made and except with RBS Hoare Govett's consent will not be capable of variation or revocation by the Placee after the time at which the Letter of Confirmation is submitted. Each Placee will also have an immediate, separate, irrevocable and binding obligation, owed to RBS Hoare Govett, to pay to RBS Hoare Govett (or as RBS Hoare Govett may direct) in cleared funds an amount equal to the product of the Placing Price and the number of Placing Shares such Placee has agreed to
subscribe.
Placing is confirmed, settlement for all Placing Shares to be acquired pursuant to the Placing will be required to be made at the same time, on the basis explained below under "Registration and Settlement" and in each
Placee's Placing Letter.
fulfilment of the conditions referred to below under "Conditions of the Placing" and to the Placing not being terminated on the basis referred to
below under "Right to terminate under the Underwriting Agreement".
each Placee will agree that its rights and obligations in respect of the Placing will terminate only in the circumstances described below and will not be capable of rescission or termination by the Placee at any time on or after Placing Admission. 10 To the fullest extent permissible by law, neither the Banks nor any of their affiliates shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, neither RBS Hoare Govett nor any of its affiliates shall have any liability (including to the extent permissible by law, any fiduciary duties) in respect of RBS Hoare Govett's conduct of the Bookbuild (including acceptance or rejection of any bid) or of such alternative method of effecting the Placing as RBS Hoare Govett and the Company may agree. Conditions of the Placing
Each of the Bank's obligations under the Underwriting Agreement in respect of the Placing Shares are conditional on, inter alia:
(a) the release of the Press Announcement in accordance with the
(b) the formal approval by the FSA of the Prospectus by not later than 5
(c) the posting of the Prospectus, Form of Proxy and Provisional Allotment
(d) the passing of the Resolutions (or with such amendments as the Banks may
(e) none of the warranties and undertakings on the part of the Company
(f) the New Facilities Agreements (as defined in the Underwriting Agreement)
(g) no matter having arisen prior to the time of Admission which might
(h) the Company not being in breach of any of its obligations under the
(i) to the extent that they are required to be delivered prior to Admission
(j) the delivery by the Company immediately prior to Admission to the Banks
(k) no event referred to in section 87G of the FSMA arising between the time
(l) the Company having applied to Euroclear for admission of the Nil-paid
(m) there not having occurred in the opinion of any of the Banks any
(n) Admission taking place by no later than 8.00 a.m. on the first Dealing
If: (i) any of the conditions contained in the Underwriting Agreement in relation to the Placing Shares are not fulfilled or, where relevant, waived by the Banks at their absolute discretion by the respective time and/or date where specified; or (ii) the Underwriting Agreement is terminated in the circumstances specified below, the Placing will lapse and the Placee's rights and obligations hereunder in relation to the Placing Shares shall cease and terminate at such time and each Placee agrees that no claim can be made by the Placee (or any person on whose behalf a Placee is acting) in respect thereof. The Banks may, at their absolute discretion and upon such terms as they think fit, waive compliance by the Company, or extend the time and/or date for fulfilment by the Company, with the whole or any part of any of the Company's obligations in relation to the conditions in the Underwriting Agreement, save that certain of the conditions, including the above condition relating to Placing Admission occurring, may not be waived. Any such extension or waiver will not affect Placees' commitments as set out in this Announcement. None of the Banks, the Company or any of their respective affiliates or any other persons shall have any liability to any Placee (or to any other person whether acting on behalf of a Placee or otherwise) in respect of any decision it may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition to the Placing nor for any decision they may make as to the satisfaction of any condition or in respect of the lacing generally and by participating in the Placing each Placee agrees that any such decision is within the absolute discretion of either of the Banks or the Company. Right to terminate under the Placing Agreement
Either of the Banks may, at its absolute discretion (acting in good faith), at any time before Admission, terminate the Underwriting Agreement by giving notice to the Company if, inter alia:
(a) any statement contained in the Prospectus, the Press Announcement, the Provisional Allotment Letter, or
(b) any matter has arisen or been discovered which would, if the Disclosure Documents were to be issued at
(c) the Company fails to comply with any of its obligations under the Underwriting Agreement or certain other
(d) there has been a breach by the Company of any of the warranties or undertakings contained in or given
(e) an event has occurred or matter arisen on or after the date of the Underwriting Agreement and before
(f) any matter or circumstance has arisen prior to the time of Admission which might reasonably be expected
(g) there shall has been a Material Adverse Change (whether or not foreseeable at the date of the
(h) there has occurred or, in the opinion of either of the Banks it is reasonably likely that there will
(i) the Company's application to the FSA for Placing Admission and/or Rights Issue Admission (as such terms
If the Underwriting Agreement is terminated in accordance with its terms, the rights and obligations of each Placee in respect of the Placing as described in this Announcement shall cease and terminate at such time and no claim can be made by any Placee in respect thereof pursuant to the Placing Letter or howsoever otherwise. By participating in the Placing, Placees agree that the exercise by either of the Banks of any right of termination or other rights or discretions under the Underwriting Agreement or the Placing and Rights Issue shall be within the absolute discretion of the Banks and that they need not make any reference to Placees pursuant to the Placing Letter or otherwise and that neither of the Banks shall have any liability to Placees whatsoever in connection with any such exercise or the timing thereof. The Placees further agree that neither of the Banks owes any fiduciary duty or other duty to any Placee in respect of any warranties, undertakings or indemnities in the Underwriting Agreement. The Prospectus A document comprising a prospectus prepared in accordance with the Prospectus Rules relating to the Company, the Placing and the Rights Issue which gives details, inter alia, of the Placing and a circular to Shareholders containing the notice of the GM, is expected to be published in the first week of November 2009. Each Placee, by accepting a participation in the Placing and/or by sending its Letter of Confirmation to RBS Hoare Govett, agrees that the content of this Announcement is exclusively the responsibility of the Company and confirms that it has neither received nor relied (nor will rely) on any other information, representation, warranty, or statement made by or on behalf of the Company or either of the Banks or any other person and non of the Banks, nor the Company, or any of their respective affiliates, or any other person will be liable for any Placee's decision to participate in the Placing based on any other information, representation, warranty or statement which the Placees may have obtained or received. Each Placee acknowledges and agrees that it has relied on its own investigation of the business, financial or other position of the Company in deciding whether or not to participate in the Bookbuild process and, if relevant, to accept a participation in the Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. Registration and Settlement Settlement of transactions in the Placing Shares (ISIN: GB00B01DW905) following Placing Admission is expected to take place within the CREST system. Settlement will be on a delivery versus payment basis. However, in the event of any difficulties or delays in admission of the Placing Shares to CREST or the use of CREST in relation to the Placing, the Company and RBS Hoare Govett may agree that the Placing Shares should be issued in certificated form. RBS Hoare Govett reserves the right to require settlement for and delivery of the Placing Shares to Placees by such other means that it deems necessary if delivery or settlement is not possible or practicable within the CREST system within the timetable set out in this Announcement or would not be consistent with the regulatory requirements in the Placee's jurisdiction. Each Placee who has been allocated Placing Shares in the Placing will, two Business Days after the GM, be sent a trade confirmation by RBS Hoare Govett (who shall be conditionally allotted such Placing Shares by the Company as nominee for the Placees upon such date) pursuant to its Placing Letter stating the number of Placing Shares allocated to it at the Placing Price, the aggregate amount owed by such Placee to RBS Hoare Govett and settlement instructions. Each Placee agrees that it will do all things necessary to ensure that delivery and payment is completed in accordance with either the standing CREST or certificated settlement instructions that it has in place with RBS Hoare Govett. It is expected that settlement between the Placees and RBS Hoare Govett will be on a T+3 basis (where T is the date that is two Business Days following the GM) unless otherwise notified by RBS Hoare Govett in accordance with the terms of the Placing Letter and the instructions set out in the trade note or confirmation. Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of 2 percentage points above LIBOR as determined by RBS Hoare Govett. Each Placee is deemed to agree that if it does not comply with these obligations, the beneficial ownership of the Placing Shares allocated to such Placee shall be transferred from such Placee to RBS Hoare Govett and RBS Hoare Govett shall hold the legal title of such Placing Shares from the time of such Placee's default and accordingly RBS Hoare Govett may sell any or all of such Placing Shares. If the proceeds of such Placing Shares are less than the aggregate amount owed by the relevant Placee plus any interest due, the relevant Placee will, however, remain liable for the shortfall and may be required to bear any stamp duty or stamp duty reserve tax (together with any interest or penalties) which may arise upon the sale of such Placing Shares by RBS Hoare Govett. If Placing Shares are to be delivered to a custodian or settlement agent, Placees should ensure that the commission payment instruction form (appended to the Placing Letter) is completed by such custodian or settlement agent and returned to RBS Hoare Govett by 5 p.m. on 29 October 2009 and that the trade confirmation is copied and delivered immediately to the relevant person within that organisation. Insofar as Placing Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Placing Shares should, subject as provided below, be so registered free from any liability to UK stamp duty or UK stamp duty reserve tax. Placees will not be entitled to receive any fee or commission in connection with the Placing. Representations and Warranties
By participating in the Bookbuild process and the Placing each Placee (and any person acting on such Placee's behalf) will give representations and warranties to each of the Banks that it:
entirety and that its acquisition of Placing Shares is subject to and based upon all the terms, conditions, representations, warranties, acknowledgements, agreements and undertakings and other information
contained herein and in the Placing Letter;
connection with the Placing as at the date of this Announcement and represents and warrants that it has not received a prospectus or other offering document in connection therewith as at the date of this
Announcement;
representation in relation to the Company or its affiliates or the Placing Shares other than as contained in the Press Announcement, and (ii) none of the Company, the Banks, their respective directors, officers, employees, agents representatives subsidiaries or affiliates (or any of them) or any person acting on behalf of any them shall have any liability for any other information, representation or warranty, provided that nothing in this paragraph shall exclude the liability of
any person for any fraudulent misrepresentation made by that person;
to, or in relation to, and no responsibility or liability will be accepted by either of the Banks or any of their respective employees, affiliates, advisers or agents or any other person as to, or in relation to, the Press Announcement or the Prospectus or any other written or oral information made available to or publicly available to it (including the Placing Letter), any person acting on its behalf or any of its or their advisers of any of them, and any liability therefore is expressly
disclaimed;
it has knowledge and experience in financial, business and international investment matters as is required to evaluate the merits and risks of subscribing for or purchasing the Placing Shares. It further confirms that it is experienced in investing in securities of this nature in this sector and is aware that it may be required to bear, and is able to bear, the economic risk of, and is able to sustain a complete loss in connection with the Placing. It further confirms that it relied on its own examination and due diligence of the Company and its associates taken as a whole, and the terms of the Placing, including the merits and risks
involved;
satisfied itself concerning legal, regulatory, tax, business and financial considerations in connection herewith to the extent it deems necessary; (b) had access to review publicly available information concerning the Company that it considers necessary or appropriate and sufficient in making an investment decision; (c) reviewed such information as it believes is necessary or appropriate in connection with its subscription for the Placing Shares; and (d) made its investment decision based upon its own judgement, due diligence and analysis and not upon any view expressed or information provided by or on behalf of the
Banks;
Banks or any person acting on its behalf may or may not have conducted with respect to the Company, its group, or the Placing and the Banks have not made any representation to it, express or implied, with respect to the merits of the Placing, the subscription for the Placing Shares, or as to the condition, financial or otherwise, of the Company, its group, or as to any other matter relating thereto, and nothing herein shall be construed as a recommendation to it to subscribe for the Placing Shares. It acknowledges and agrees that no information has been prepared by the
Banks or the Company for the purposes of this Placing;
neither of the Banks is making any recommendations to or advising it regarding the suitability or merits of any transaction it may enter into in connection with the Placing, the Rights issue or otherwise and that it is not, and does not regard itself as, a client of either of the Banks in connection with the Placing and/or the Rights Issue, and that the Banks are acting solely for the Company in relation to the Placing and the Rights Issue and will not regard any other person as their client in relation to the Placing and Rights Issue and will not be responsible to it for providing the protections afforded to their clients or for
advising it on the Placing and or the Rights Issue;
applicable legal and regulatory provisions, engage in transactions in relation to the ordinary shares of the Company and/or related instruments for their own account or otherwise and, except as required by applicable law or regulation, the Banks will not make any public disclosure in relation to such transactions; 10 acknowledges, undertakes and agrees with each of the Banks and the Company that where it is a related party of the Company for the purposes of the Listing Rules that (a) the acquisition of the Placing Shares comprised in its Placing Participation as provided for herein shall be conditional upon the approval of the Resolution at the EGM in relation to its subscription for such Placing Shares in the Placing, (b) it will not vote on such Resolution and will take all reasonable steps to ensure that its associates do not vote on such Resolution and (c) it will provide all information requested by either of the Banks or the Company for the purposes of completing the disclosure in the Prospectus in relation to it and its associates as required by the Listing Rules and the Prospectus Rules; 11 (a) is duly incorporated and validly existing under the laws of its jurisdiction of incorporation; (b) has power under its constitutional documents and has obtained all necessary authorities (including, without limitation, all relevant members' resolutions) to acquire and pay for the Placing Shares in the manner proposed and to enter into and perform its obligations pursuant to the Placing Letter and the Letter of Confirmation; (c) there are no governmental or regulatory consents or other third party approvals, authorisations or orders required (including, without limitation, any consent of the Board of Governors of the U.S. Federal Reserve System) in order for it to acquire and pay for the Placing Shares in the manner proposed and to enter into and perform it obligations pursuant to the Placing Letter and the Letter of Confirmation that have not been or will not prior to the issue of the Placing Shares have been obtained. It represents and warrants that it has complied and will comply with all applicable p 12 the entering into of the agreement constituted by the telephone conversation referred to above, the Placing Letter and the Letter of Confirmation and performance of its obligations pursuant thereto and the acquisition of and payment for the Placing Shares will comply with all agreements to which it is a party or by which it or any of its properties or assets are bound and which is material to its participation and its obligations in respect thereof. The Letter of Confirmation will have been duly authorised, executed and delivered by it and the agreement constituted by its telephone conversation, this Placing Letter and the Letter of Confirmation constitutes the valid and legally binding agreement; 13 has funds available to pay to RBS Hoare Govett the full amounts referred to in and pursuant to the Placing Letter as and when due; 14 acknowledges and agrees that the Placing Shares are being offered and sold to it pursuant to Regulation S in a transaction not involving a public offering of securities in the United States and the Placing Shares have not been and will not be registered under the Securities Act. It acknowledges that the Placing Shares may not be offered, sold, pledged, resold, transferred, delivered or distributed within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act; 15 was outside of the United States during any offer or sale of the Placing Shares to it and it is acquiring the Placing Shares in an "offshore transaction" (within the meaning of Regulation S); 16 understands and agrees that if in the future it decides to dispose of any of the Placing Shares, it may do so only in compliance with the Securities Act and applicable state securities laws and the securities laws of any other relevant jurisdiction, as then in effect; 17 is acquiring the Placing Shares for its own account (or for the account of its affiliates or funds managed by it or its affiliates with respect to which it has investment discretion), not with a view to, or for resale in connection with, the distribution thereof or the distribution of the Placing Shares, into the United States. It represents and warrants that, if it is acquiring Placing Shares for one or more managed accounts, it is authorised in writing by each managed account to acquire such Placing Shares on their behalf; 18 is not resident or domiciled in or a national of the United States or any of the Excluded Territories nor is it acquiring the Placing Shares for the benefit of such a person or with a view to resale to such a person; 19 warrants that (i) it is a person whose ordinary activities involve it in acquiring, holding, managing or disposing of investments (as principal or agent) in the course of its business and a qualified investor within the meaning of section 85(7) of the FSMA, (ii) if in the UK, it is a person of a kind described in articles 19(5) or 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended), (iii) if it is a resident in the EEA, it is a 'Qualified Investor' within the meaning of the law in the Relevant Member State implementing Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC); and (iv) it does not intend to offer or sell or otherwise deal with the Placing Shares in any way which would result in an offer to the public in the UK within the meaning of the FSMA or in any other jurisdiction or require registration or prospectus publication or similar actions in the UK or any other jurisdiction; 20 is aware of, has complied with and will continue to comply with any obligations it has under the Criminal Justice Act 1993, section 118 of the FSMA and the Proceeds of Crime Act 2002 to the extent applicable to it. It is also aware of its obligations in connection with money laundering under the Proceeds of Crime Act 2002 and it complied with the Money Laundering Regulations 1993, 2003 and 2007 and, if it is making payment on behalf of a third party, it has obtained and recorded satisfactory evidence to verify the identity of the third party as required by relevant law and regulations; 21 represents and warrants that it is not acting in concert (within the meaning given in the City Code on Takeovers and Mergers) with any other Placee or any other person in relation to the Company; 22 to the fullest extent permitted by law, it acknowledges and agrees to the disclaimers contained in the Press Announcement; 23 warrants that it is a sophisticated investor with knowledge and experience in financial and business matters, including but not limited to sales and purchases of securities, as to be capable of evaluating the merits and risks of the Placing Shares; 24 warrants that it has independently, without reliance upon any other party and based on such information it has deemed appropriate in your independent judgment, made its own analysis and decision with respect to its investment in the Placing Shares; 25 represents and warrants that it is not a person whose business is or includes, issuing depository receipts or a person whose business is, or includes, the provision of clearance services for the purchase or sale of securities or a nominee of any such person; 26 has made its own independent investigation and appraisal of the business, results, financial condition, prospects, creditworthiness, status and affairs of the Company and it has made its own investment decision to acquire the Placing Shares; 27 has read, agreed with, understood and accepted the terms and conditions of this letter and the Press Announcement and, accordingly, to have irrevocably agreed in accordance with such terms and conditions to acquire and pay for the number of Placing Shares comprised in its Placing Participation and its related rights under the Rights Issue in full; 28 acknowledges that neither the Company nor any of its affiliates nor any other person (including the Banks or any of their affiliates) has made any representations, express or implied, to it with respect to the Company, the Placing Shares or the accuracy, completeness or adequacy of any financial or other information concerning the Company or the Placing Shares, other than (in the case of the Company and its affiliates only) the information contained or incorporated by reference in the Press Announcement. It acknowledges that it has not relied on any information contained in any research reports prepared by the Banks or any of their respective affiliates; 29 declares that sections 67, 70, 93 and 96 of the Finance Act 1986 (depositary receipts and clearance services) do not apply on your acquisition of Placing Shares (or that if this is not applicable it has informed us in writing of its status for stamp duty and stamp duty reserve tax purposes); 30 acknowledges that any agreements entered into by it pursuant to these terms and conditions, including any non-contractual obligations arising out of or in connection with these terms and conditions, shall be governed by and construed in accordance with the laws of England and Wales and it submits (on behalf of itself and on behalf of any person on whose behalf it is acting) to the exclusive jurisdiction of the English courts as regards any claim, dispute or matter arising out of any such contract or non-contractual obligation, except that enforcement proceedings in respect of the obligation to make payment for the Placing Shares (together with any interest chargeable thereon) may be taken by the Company or any of the Banks in any jurisdiction in which the relevant Placee is incorporated or in which any of its securities have a quotation on a recognised stock exchange; 31 agrees that the Company, the Banks and their respective affiliates and others will rely upon the truth and accuracy of the foregoing representations, warranties, acknowledgements and undertakings which are given to each of the Banks on its own behalf and on behalf of the Company and are irrevocable; 32 acknowledges that time shall be of the essence as regards obligations pursuant to this Announcement; and 33 agrees to indemnify on an after-tax basis and hold the Company, each of the Banks and their respective affiliates harmless, on an after-tax basis, from any and all costs, claims, liabilities, losses and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings in this Appendix and further agrees that the provisions of this Appendix shall survive after completion of the Placing. The above representations, warranties and undertakings are incorporated by reference into the Placing Letter and in the event of any inconsistency between the representations, warranties and undertakings set out in this Appendix and those set out in the Placing Letter, the representations, warranties and undertakings set out herein shall take precedence and prevail. The agreement to settle a Placee's Placing Participation (and/or the participation of a person for whom such Placee is contracting as agent) free of UK stamp duty and UK stamp duty reserve tax depends on the settlement relating only to subscription by it and/or such person direct from the Company or from RBS Hoare Govett (as nominee or agent for the Placees) for the Placing Shares in question. Such agreement assumes that the Placing Shares are not being subscribed to or purchased for in connection with arrangements to issue depositary receipts or to transfer the Placing Shares into a clearance service. If there are any such arrangements, or the settlement relates to any other dealing in the Placing Shares, UK stamp duty or UK stamp duty reserve tax may be payable, for which neither the Company nor RBS Hoare Govett will be responsible. If this is the case, the relevant Placee should seek its own advice and notify RBS Hoare Govett accordingly. In addition, Placees should note that they will be liable for any UK stamp duty and UK stamp duty reserve tax and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the UK by them or any other person on the acquisition by them of any Placing Shares or the agreement by them to subscribe for any Placing Shares. Each Placee and any person acting on behalf of the Placee acknowledges and agrees that either Bank or any of their affiliates may, at its absolute discretion, agree to become a Placee in respect of some or all of the Placing Shares. When a Placee or person acting on behalf of the Placee is dealing with RBS Hoare Govett, any money held in an account with RBS Hoare Govett on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money within the meaning of the rules and regulations of the FSA made under the FSMA. The Placee acknowledges that the money will not be subject to the protections conferred by the client money rules; as a consequence, this money will not be segregated from RBS Hoare Govett's money in accordance with the client money rules and will be used by RBS Hoare Govett in the course of its own business; and the Placee will rank only as a general creditor of RBS Hoare Govett. All times and dates in this Announcement may be subject to amendment. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. For the avoidance of doubt, the commitments, representations, warranties and undertakings of any Placee under the Placing are not conditional on any of the expected dates in this Announcement actually being achieved. RBS Hoare Govett shall notify the Placees and any person acting on behalf of the Placees of any changes. 10. General The Prospectus will give further details of the Firm Placed Shares, the Nil Paid Rights, the Fully Paid Rights and the New Shares (together "the Securities") to be offered pursuant to the Firm Placing and the Rights Issue. A copy of the Prospectus when published will be available from the registered office of e2v at 106 Waterhouse Lane, Chelmsford, Essex CM1 2QU during usual business hours on any weekday (Saturdays, Sundays and Bank Holidays excepted) and from the offices of Macfarlanes LLP, 20 Cursitor Street, London EC4A 1LT. The Prospectus will also be available on the Company's website, www.e2v.com This announcement is not a prospectus but an advertisement and investors should not subscribe for any Securities referred to in this announcement except on the basis of the information contained in the Prospectus. This announcement does not constitute an offer to sell, or a solicitation of an offer to subscribe for any Securities being issued in connection with the Firm Placing and the Rights Issue, in any jurisdiction in which such offer or solicitation is unlawful. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, New Zealand, South Africa or Switzerland or any other jurisdiction where the same would be unlawful. This announcement does not constitute, or form a part of, any offer or solicitation to purchase or subscribe for securities in the United States. The Securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of any of the Securities in the United States. The Securities have not been approved or disapproved by the US Securities and Exchange Commission, any state's securities commission in the United States or any other US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Securities or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence. The Securities will not be registered under the securities laws of Australia, Canada, Japan, New Zealand, South Africa or Switzerland and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an applicable exemption from and in compliance with any applicable securities laws. There will be no public offer in any of Australia, Canada, Japan, New Zealand, Switzerland or South Africa. Rothschild and RBS Hoare Govett , each of which is authorised and regulated in the United Kingdom by the FSA, are acting exclusively for the Company and no one else in connection with the Firm Placing and the Rights Issue and Admission and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Firm Placing and the Rights Issue and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Firm Placing and the Rights Issue and admission or any matters referred to in this announcement. This announcement has been issued by and is the sole responsibility of the Company. None of Rothschild nor RBS Hoare Govett (or any of their respective affiliates or agents) accept any responsibility whatsoever for, and make no representation or warranty, express or implied, in relation to, the contents of this announcement (including its accuracy, completeness or verification) or any other statement made or purported to be made by them, or on their behalf, in connection with the Company, the Firm Placed Shares, the Firm Placing, the Nil Paid Rights, the Fully Paid Rights, the New Shares or the Rights Issue. Each of Rothschild and RBS Hoare Govett accordingly disclaims to the fullest extent permitted by law all and any responsibility and liability, whether arising in tort, contract or otherwise in respect of this announcement or any such statement. Neither the content of e2v's website nor any website accessible by hyperlinks on e2v's website is incorporated in, or forms part of, this announcement. The distribution of this announcement and/or the Prospectus and/or the Provisional Allotment Letters and/or the transfer of Securities into jurisdictions other than the United Kingdom may be restricted by law. No action has been taken by the Company or any of Rothschild or RBS Hoare Govett that would permit an offering of such rights or shares or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement contains certain forward-looking statements which may include reference to one or more of the following: the Group's financial condition, results of operations, cashflows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditure, competitive positions, growth opportunities for existing products, sales, prices of products, plans and objectives of management and other matters. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "annualised", "goal", "target", "aim", "may", "will", "would", "could" or "should" (or in each case, their negative or other variations or comparable terminology). Statements in this announcement that are not historical facts are hereby identified as "forward-looking statements". Such forward-looking statements, including, without limitation, those relating to future business prospects, revenue, liquidity, capital needs, expected cost savings, interest costs and income, in each case relating to e2v, wherever they occur in this announcement, are not necessarily based on assumptions reflecting the views of e2v and involve a number of known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. Such forward-looking statements should, therefore, be considered in the light of various important factors. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, without limitation: economic and business cycles, the terms and conditions of e2v's financing arrangements, including fluctuations in interest rates, foreign currency rate fluctuations, competition in e2v's principal markets, acquisitions or disposals of businesses or assets and trends in e2v's principal industries and markets and the impact of the acceleration of the Group's "Fit for the Future" restructuring programme. These forward-looking statements are not guarantees of future performance. Rather, they are based on current views and assumptions and involve known and unknown risks, uncertainties and other factors, many of which are outside the control of the Company and are difficult to predict, that may cause actual results to differ materially from any future results or developments expressed or implied from the forward-looking statements. These forward-looking statements speak only as of the date of this announcement. The information and opinions contained in this announcement are subject to change without notice and, subject to any obligations under the Prospectus Rules, Listing Rules or the Disclosure and Transparency Rules, and save as required by law, e2v assumes no responsibility or obligation to update publicly or review any of the forward-looking statements contained herein and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein to reflect any change in e2v's expectations with regard thereto or any change in events, conditions or circumstances on which such statement is based. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. No statement in this announcement is intended to be a profit forecast.
DEFINITIONS The following definitions apply throughout this announcement, unless the context requires otherwise:
Agreement"
"Existing Lending Facilities" the lending facilities provided under the Existing Facility
"LSE"
"Memorandum of Association" or the memorandum of association of the Company
"Memorandum"
"Provisional Allotment Letter" the renounceable provisional allotment letter expected to be
End This information is provided by RNS The company news service from the London Stock Exchange END
IOEEAXENAEANFEE More |
||
| 29-10-09 | RNS |
|
|
RNS Number : 5687B e2v technologies PLC 29 October 2009 29 October 2009 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR THEIR RESPECTIVE TERRITORIES. NOTHING IN THIS ANNOUNCEMENT IS AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER RESTRICTED JURISDICTION OF ANY SECURITIES REFERENCED HEREIN. SUCH SECURITIES MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER THE US SECURITIES ACT OF 1933, AS AMENDED. NO PUBLIC OFFERING OF THE SECURITIES IS BEING OR WILL BE MADE IN THE UNITED STATES. This announcement has been issued by and is the sole responsibility of e2v. It shall not constitute, or form part of, any offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale or purchase of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The availability of the Firm Placing and the Rights Issue to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any applicable requirements. This announcement is an advertisement and does not constitute a prospectus. Nothing in this announcement should be interpreted as a term or condition of the Firm Placing or the Rights Issue. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Firm Placed Shares, Nil Paid Rights, Fully Paid Rights, and/or New Shares must be made only on the basis of the information contained in and incorporated by reference into the Prospectus. Any person receiving this announcement is advised to exercise caution in relation to the Firm Placing and Rights Issue. If in any doubt about any of the contents of this announcement, independent professional advice should be obtained.
E2V TECHNOLOGIES PLC
PROPOSED FIRM PLACING AND RIGHTS ISSUE
AND
REFINANCING OF THE GROUP'S LENDING FACILITIES The Board of Directors of e2v technologies plc ("e2v" or the "Company" or the "Group") today announces a fully underwritten Firm Placing and Rights Issue to raise gross proceeds of approximately £56 million. The Firm Placing and the Rights Issue are subject to approval by Shareholders at a General Meeting. A prospectus containing a notice of general meeting will be posted to shareholders shortly. In conjunction with the Firm Placing and the Rights Issue, the Board today announces that it has reached agreement on new committed lending facilities and also outlines the potential extensive acceleration of the "Fit for the Future" restructuring programme. In a separate announcement e2v has today announced its interim results for the six months ended 30 September 2009. Highlights of the capital raising and new debt facilities
Overview of management actions and restructuring programme e2v is today announcing proposals for an extensive acceleration of the Group's "Fit for the Future" programme. The potential restructuring programme, which will affect the Group's operations in France and the UK, is subject to formal employee consultations which are anticipated to be completed by April 2010. The potential French restructuring programme includes the Imaging business at Grenoble. Consultation is being undertaken on the options for the CCD wafer fab facility which may include its closure along with acceleration of the development of a "fabless" based CMOS Imaging business. The latter may complement the UK-based high-end CCD Imaging business. This consultation also includes options on the cost structure of the Specialist Semiconductor activities and support functions based in Grenoble. The potential restructuring of operations in the UK relates to the transfer to Chelmsford of the manufacturing activity of the Lincoln based microwave and high speed electronics (MHSE) business. Consideration is being given to other cost reduction activities as part of the continuing focus on cost and capacity management. The overall cost of these steps to restructure the Group's operations is anticipated to be approximately £33m and would, on completion, provide annual savings of approximately £26m. e2v has also today announced that the Company proposes to raise £55.8m gross by the issue of new shares through a firm placing and rights issue. This will reduce the Group's debt profile, facilitate the potential "Fit for the Future" programme and provide a stronger financial base for the Group. The firm placing and rights issue are subject to approval by shareholders at a General Meeting scheduled to be held on 20 November 2009. In addition, on 29 October 2009, the Group entered into a new term and revolving facility of £105m, that becomes available on completion of the firm placing and rights issue, to refinance the existing facilities agreement. This facility will run for three years until 31 December 2012. With these changes, e2v's operational focus going forward will be on three core divisions:
along with continuing to review the options for disposal of other non core assets. Current trading and prospects
Expected timetable of principal events (1) Each of the times and dates in the table below is indicative only and may be subject to change.
2009
London Stock Exchange
Exchange
registration of renunciation of Provisional Allotment
Letters
Stock Exchange Notes: (1) The times and dates set out in the expected timetable of principal events above and mentioned throughout this announcement may be adjusted by the Company (in consultation with Rothschild and RBS Hoare Govett), in which event details of the new times and dates will be notified to the UKLA, the London Stock Exchange and, where appropriate, Qualifying Shareholders and Placees. References to times in this timetable are to London times unless otherwise stated. This summary should be read in conjunction with the full text of this announcement. A prospectus relating to the Firm Placing and the Rights Issue (the "Prospectus") is expected to be published shortly and will be available at the registered office of e2v at 106 Waterhouse Lane, Chelmsford, Essex CM1 2QU and on the Company's website, www.e2v.com. Rothschild is acting as Financial Adviser to the Company and Sponsor to the Firm Placing and the Rights Issue. RBS Hoare Govett is acting as Bookrunner and Underwriter. Contacts For further information, please contact:
ExecutiveCharles Hindson, Group Finance Director
HimsworthRoger HemmingJohn Byrne
Corporate Broking:John MacGowanAlexander
GartonSyndication:Lee Morton
Shareholder enquiries If you have any queries about the Firm Placing and the Rights Issue, please telephone the Shareholder Helpline on 0871 384 2927 or, if you are calling from outside the United Kingdom, +44 121 415 0268. This helpline is available between 8.30 a.m. to 5.30 p.m. on any Business Day.
Calls to the 0871 384 2927 number are charged 8p per minute (including VAT) from a BT landline. Other service providers' costs may vary. Calls to the +44 121 415 0268 number from outside the UK are charged at applicable international rates. Different charges may apply to calls made from mobile telephones and calls may be recorded and monitored randomly for security and training purposes. Please note that for legal reasons, the Shareholder Helpline is only able to provide you with information contained in this announcement and, when published, the Prospectus and information relating to e2v's register of members and is unable to give advice on the merits of the Firm Placing and the Rights Issue or provide legal, financial, tax or investment advice. If you are in any doubt as to the action you should take, you should immediately seek your own financial advice from your stockbroker, bank manager, solicitor, accountant, fund manager or other independent financial adviser authorised under FSMA or, if you are outside the UK, by another appropriately authorised independent financial adviser.
1. Introduction The Board of e2v today announces that e2v is proposing to raise gross proceeds of approximately £56 million by way of the Firm Placing and the Rights Issue. The Firm Placing, comprising in aggregate 31,428,571 Firm Placed Shares (representing approximately 50 per cent. of the Company's existing issued share capital) will raise £22 million. The Firm Placing Price represents a 1 per cent. premium to the closing price of 69 pence per Share on 28 October 2009 (being the last trading day prior to the date of the announcement of the Firm Placing and the Rights Issue). The Firm Placing is subject to Shareholder approval. Pursuant to the Rights Issue it is proposed that 120,854,782 New Shares be issued by way of rights to Qualifying Shareholders and Placees at 28 pence per New Share. The Rights Issue is expected to raise gross proceeds of £34 million. The Rights Issue Price represents:
The Firm Placing and the Rights Issue have been fully underwritten by RBS Hoare Govett and are conditional, inter alia, upon the passing of the Resolutions by Shareholders at the General Meeting. Rothschild is acting as Financial Adviser to e2v and as Sponsor to the Firm Placing and the Rights Issue. In addition, also announced today, the Group entered into a new term and revolving facility of £105 million to refinance the Existing Facilities Agreement. The New Lending Facilities will only refinance the Existing Lending Facilities if the Firm Placing and the Rights Issue complete and will be drawn down on 31 December 2009. In the event that the Firm Placing and the Rights Issue do not complete, the New Lending Facilities will not refinance the Existing Lending Facilities. 2. Background to the Firm Placing and Rights Issue e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for the aerospace & defence, commercial & industrial and medical & science markets. The Company has been quoted on the London Stock Exchange since 2004 and, since that time, the Company's sales have grown from £98m in the financial year ended 31 March 2004 to £233m in the 2008/2009 Financial Year. The Group specifically targets markets that exhibit long term growth, high barriers to entry, require a significant proportion of bespoke design and have a limited number of competitors. e2v does not seek to compete in commoditised markets. The Group's business strategy has four key elements:
Resulting from the Group's business strategy set out above, for over the last three financial years up until 31 March 2009, the Group's sales have increased by 107.7 per cent. (from £112.3m to £233.2m) and Adjusted profit before tax and net finance costs has increased by 83.9 per cent. (from £14.9m to £27.4m). This growth has predominantly been achieved through acquisitions. In addition, the Company has paid aggregate dividends of £13m in the three years to 31 March 2009. The Group has introduced 391 new products in the last 3 financial years which accounted for 26 per cent. of sales during the 2008/2009 Financial Year. e2v's sub-systems business activities account for 18.4 per cent. of sales in the 2008/2009 Financial Year. Between the end of the 2006/2007 Financial Year and the end of the 2008/2009 Financial Year, the Group reduced average net headcount after acquisitions across the Group by 5.2 per cent., increased operating profit per employee by 38.4 per cent. and improved operating cash flow by 62.6 per cent. However, the Group has not been immune to the deteriorating economic conditions over the last 12 months which have culminated in recession in many developed economies. In particular, the Group has, since December 2008, seen a progressive weakening in demand across some of its commercial & industrial market sectors and in its medical market sector. Additionally, during the first quarter of the current financial year, delayed programme phasing was noticeable within the US business of the specialist semiconductor division, and since then there have been deferrals in the award of certain defence contracts throughout the Group's geographic markets. Financial results for the 2009/2010 Half Year were as follows:
In addition, the Group has reduced its net borrowings by £32m since 31 March 2009, to £105m. Like for like sales for the 2009/2010 Half Year reduced by 26 per cent. when compared with the 2008/2009 Half Year. The Group's acquisition programme has been largely funded by debt and in currencies, predominantly the Euro and the US dollar, that matched the acquired asset base. The weakening of Sterling in the 12 months to 31 March 2009 against both the Euro and the US dollar had significant ramifications for the Company. Whilst exports from Europe, and particularly the UK, to the United States are now more competitively priced against products of the Group's US competitors, the Group's multi-currency borrowings had, when translated into Sterling for reporting and covenant testing purposes, significantly increased, contributing some £19.4m to the increase in the Group's net borrowings of £137.3m as at 31 March 2009. In the 2009/2010 Half Year there was a decrease in net borrowings of £8.7m as a result of exchange movements. 3. Current actions by management to improve profitability To minimise the impact of the difficult trading conditions in this challenging environment, the Directors have instigated additional specific measures in the 2009/2010 Half Year to control further the Group's cost:
In addition, to further preserve cash and reduce indebtedness:
Notwithstanding the early success of the actions described above, the prolonged challenging trading conditions continue to place pressure on the Group's sales, profits and cash flows. 4. The Restructuring Programme and planned actions by management to improve profitability Further changes to the Group's business are being proposed which would be expected to provide the increased flexibility and scaleability required to match effectively the Group's capacity to demand and to maximise opportunities when economic conditions improve. This is likely to be achieved through the potential extensive acceleration of the Group's established "Fit for the Future" restructuring programme, which the Directors' believe would significantly reduce the fixed cost base of the Group's business to ensure that the Group's business resources are consistent with the Directors' current view of future demand. In addition to the focus on cost reduction, the proposed restructuring programme is intended to streamline the Group's operations, optimising business processes such that the Group operates at improved efficiency levels, which the Directors anticipate will significantly enhance various customer and operational metrics, most notably customer satisfaction, inventory levels, on-time delivery, production lead times and product quality. Any restructuring programme, which would affect the Group's operations in France, and in the UK, would be subject to formal employee consultations, in compliance with applicable laws and regulations. In e2v's facility based in Grenoble, France, it is proposed that the business activities associated with the imaging devices division should be refocused around a fabless CMOS business model, which provides a complementary activity to the CCD focused UK imaging operations. It is also expected that that the Grenoble based activities associated with the specialist semiconductors division would be enhanced as a consequence of this programme. The Group had, for a number of months, recognised the need to reduce its overall imaging CCD fabrication capacity for the long term and had considered the gradual migration of its UK activities into its operations in Grenoble. However, following the rapid reduction in demand from the markets primarily served by the Grenoble facility, the potential closure of the imaging CCD fabrication facility based in Grenoble (subject to consultation with the French workers union) is considered by the Directors to be the optimum solution to rapidly reduce overall capacity at a lower cost and with the least technical and commercial risk. In addition, the Group is considering how to address surplus capacity requirements in its other operations, principally in the UK. The Lincoln based microwave and high speed electronics business was subject to a previously announced potential disposal programme. After lengthy discussions with potential buyers however, the Board is considering whether the transfer of the majority of the manufacturing facilities from Lincoln to other of the Group's sites would create more value for Shareholders than a sale at the price that was indicated by potential buyers. Further restructuring activity at the Chelmsford facility may also be considered in the future in addition to the creation of an engineering centre in Lincoln. Subject to compliance with the applicable consultation obligations, the overall cost of any restructuring programme (including redundancy, move and other closure costs), is estimated to be approximately £33m and would on completion provide annual savings of approximately £26m. As part of any restructuring programme, the Group may also consider introducing, for example, new working practices, incorporating flexible hours for appropriate staff. The Board believes this is likely to enable the Group to better match capacity to demand and therefore respond more rapidly to any potential upturn in customer demand. The Board believes that any restructuring programme would create a platform for the long-term strategic development of the Group to create value for Shareholders, and would support a medium term emphasis on growth, by the:
In addition, as part of the restructuring programme, the senior management team has already been reduced from 13 to 8, and strengthened by the appointment of Charles Hindson as Group Financial Director in May 2009 and Chris Geoghegan as Chairman on 1 October 2009. 5. Reasons for the Firm Placing and the Rights Issue Against this background, in addition to the measures already taken, e2v today announces the Firm Placing and the Rights Issue to raise gross proceeds of £56 million in order to reduce the Group's debt profile and provide a stronger financial base. Reducing the Group's debt profile The proceeds of the Firm Placing and the Rights Issue will be used to repay existing debt. The Group will, as required pursuant to the terms of the Existing Facilities Agreement and as a condition to the New Lending Facilities becoming available, use at least £30m of the net proceeds of the Firm Placing and the Rights Issue to reduce the amounts outstanding under the Existing Facilities Agreement (such amount to be held in a holding account between completion of the Firm Placing and the Rights Issue and payment of the £30m on 31 December 2009). The remaining net proceeds of £22 million (the "Additional Proceeds") will also be used to reduce net borrowings. Stronger financial base The Board believes this reduced level of indebtedness and increased headroom under the financial covenants in the Group's debt facilities following the reduction described above, should provide the Group with the appropriate financial flexibility to implement, and fund from anticipated operational cash flows, the potential acceleration of the "Fit for the Future" restructuring programme. It should also provide the Group with a stronger financial base, which should ensure that the Group maintains access to cost effective sources of funding and should give the Group a stronger credit standing. Moreover, the Board believes this stronger financial base means the Group should be able to respond to opportunities that may arise to accelerate growth either organically or, in due course, if the Directors consider it prudent to do so and with the consent of the Group's lending banks, through the addition of complementary businesses and technologies, particularly if attractive consolidation opportunities were to arise. The net proceeds of the Firm Placing and the Rights Issue will be used to repay existing debt and, consequently, the Directors believe that net borrowings, following receipt of proceeds from the Firm Placing and the Rights Issue, will be at an appropriate level taking into account the planned restructuring. The Directors expect that the Firm Placing and the Rights Issue should make a positive contribution to total earnings in the medium term as it will provide the Group with the financial resources and flexibility to enable the Group to continue to pursue the restructuring programme in a manner which the Directors believe will have a positive effect on earnings. However, the Directors expect that the increased number of Shares in issue following the Firm Placing and the Rights Issue will have a negative effect on the Company's earnings per Share for the same period. 6. New Lending Facilities Also announced by the Board today, the Group entered into new term and revolving facilities of £105 million (the "New Facilities Agreement") to refinance the Existing Lending Facilities. The New Lending Facilities can only be utilised if, amongst other things, the Firm Placing and the Rights Issue complete and will be drawn down on 31 December 2009. In the event that the Firm Placing and the Rights Issue does not complete, the New Lending Facilities will not refinance the Existing Lending Facilities. At least £30m from the proceeds of the Firm Placing and Rights Issue will be applied in reduction of amounts outstanding under the Existing Lending Facilities before the Existing Lending Facilities are refinanced by the New Lending Facilities. The principal terms of the New Facilities Agreement are:
The Directors believe that the New Lending Facilities will provide the Group with increased financial flexibility going forward, including by virtue of an extended maturity date for the New Lending Facilities and through the reduction of amounts outstanding under the facilities (as compared to under the Existing Facilities Agreement) which is to be made from the proceeds of the Firm Placing and the Rights Issue. 7. Dividends and dividend policy The Company did not pay a final dividend for the financial year ended 31 March 2009, nor did it pay an interim dividend for the period ended 30 September 2009. Pursuant to the terms of the Existing Facilities Agreement (and the New Facilities Agreement if and when it comes into effect), the Company has undertaken only to declare and pay dividends if certain covenant tests are met and no default exists under the facility agreement in force at the relevant time. The Board remains committed to pursuing a progressive dividend policy and, assuming the Company can meet the relevant tests in the Existing Facilities Agreement or the New Facilities Agreement (as the case may be), e2v will resume dividend payments once market conditions improve and the Directors believe it is prudent to do so. The level of future dividend payments will take into account the Company's underlying earnings, cash flows and capital investment plans, the requirement to maintain an appropriate level of dividend cover and the prevailing market outlook. 8. General meeting Notice of the General meeting will be made shortly upon publication of the prospectus in line with the indicative timetable in the summary of this announcement. All the Resolutions to be proposed at the General meeting are required in order to enable the Company to implement the Firm Placing, the Rights Issue and, accordingly, the Firm Placing, the Rights Issue are conditional on the Resolutions being passed. Appendix 9. TERMS AND CONDITIONS OF THE FIRM PLACING THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND. IMPORTANT INFORMATION ON THE PLACING FOR PLACEES ONLY. MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE PLACING. THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN ARE FOR INFORMATION PURPOSES ONLY AND ARE DIRECTED ONLY AT: (A) PERSONS IN RELEVANT MEMBER STATES WHO ARE QUALIFIED INVESTORS PURSUANT TO THE PROSPECTIVE DIRECTIVE (DIRECTIVE 2003/71/EC); AND (B) IN THE UNITED KINGDOM, QUALIFIED INVESTORS WHO ARE RELEVANT PERSONS PURSUANT TO FSMA (IN EACH CASE A "RELEVANT PERSON"). THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN MUST NOT BE ACTED ON OR RELIED ON BY PERSONS WHO ARE NOT RELEVANT PERSONS. ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS APPENDIX AND THE TERMS AND CONDITIONS SET OUT HEREIN RELATES IS AVAILABLE ONLY TO RELEVANT PERSONS AND WILL BE ENGAGED IN ONLY WITH RELEVANT PERSONS. THIS APPENDIX DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY.
Persons who are invited to and who choose to participate in the Placing, by making an oral or written offer to subscribe for Placing Shares (each, a "Placee"), will be deemed to have read and understood this Announcement, including this Appendix, in its entirety and to be making such offer on the terms and conditions contained herein, and to be providing the representations, warranties, acknowledgements, and undertakings contained in this Appendix. In particular, each such Placee represents, warrants and acknowledges that:
(a) it is a Relevant Person (as defined above) and undertakes that it will
(b) (i) it is a person whose ordinary activities involve it in acquiring,
(c) it is outside the United States of America (including its territories
(d) it is not (i) acquiring the Placing Shares for the account of a person
(e) it is not resident or domiciled in or a national of Australia, Canada,
This Appendix and the Announcement of which it forms part does not constitute, or form part of, any offer to sell or issue or the solicitation of an offer to buy or subscribe for Placing Shares in any jurisdiction in which such offer or solicitation is or may be unlawful including, without limitation, the United States and any of the Excluded Territories. This Announcement and the information contained herein is not for release, publication or distribution, directly or indirectly, in or into the United States or any of the Excluded Territories, or any jurisdiction in which such publication or distribution is unlawful. No public offer of securities of the Company is being made in the United Kingdom, the United States or elsewhere. In particular, the Placing Shares referred to in this Appendix and the Announcement of which it forms part have not been and will not be registered under the Securities Act or any State of the United States, and may not be offered, sold or transferred, directly or indirectly in or into the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable State securities laws. The Placing Shares are being offered and sold outside the United States in accordance with Regulation S. The Placing Shares have not been approved or disapproved by the US Securities and Exchange Commission, any State securities commission or other regulatory authority in the United States, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing or the accuracy or adequacy of this Announcement. Any representation to the contrary is a criminal offence in the United States. The distribution of this Appendix, the Announcement of which it forms part and the Placing and/or issue of the Placing Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or RBS Hoare Govett or NM Rothschild & Sons Limited, acting as sponsor in relation to the Placing and Rights Issue (together with RBS Hoare Govett the "Banks" and each a "Bank") or any of their respective affiliates that would permit an offer of the Placing Shares or possession or distribution of this Announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this Announcement comes are required by the Company and the Banks to inform themselves about and to observe any such restrictions. The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with or registered by, the Australian Securities and Investments Commission, the Japanese Ministry of Finance, the New Zealand Securities Commission, the South African Reserve Bank or the Swiss Federal Banking Commission; and the Placing Shares have not been, nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of any of the Excluded Territories. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into the United States, or any of the Excluded Territories, or any other jurisdiction outside the United Kingdom. Each Placee, by participating in the Placing, agrees that it has neither received nor relied on any information, representation, warranty or statement made by or on behalf of either of the Banks or the Company other than publicly available information and neither the Banks nor the Company or any person acting on such person's behalf nor any of their affiliates has or shall have any liability for any Placee's decision to accept this invitation to participate in the Placing based on any other information, representation, warranty or statement. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of this Appendix or the Announcement of which it forms part should seek appropriate advice before taking any action. Details of the Placing Agreement and the Placing Shares The Banks have entered into a Firm Placing and Rights Issue Underwriting and Sponsor Agreement (the "Underwriting Agreement") with the Company under which RBS Hoare Govett has, on the terms and subject to the conditions set out therein and as agent for and on behalf of the Company, undertaken to use reasonable endeavours to procure subscribers for the Placing Shares at the Placing Price. Subject to the terms and conditions of the Underwriting Agreement, in the event that Placees cannot be procured for the entire amount of the Placing Shares or if a Placee has unconditionally agreed to subscribe for Placing Shares pursuant to its Placing Letter but fails to make to payment therefore, RBS Hoare Govett has agreed itself to subscribe for such Placing Shares at the Issue Price. The Placing Shares will, when issued and fully paid, be credited as fully paid and will rank pari passu in all respects with the existing issued ordinary shares in the capital of the Company ("Ordinary Shares") including the right to receive all dividends and other distributions declared, made or paid after the date of issue, including the right to participate in the Rights Issue in respect of the Placing Shares pursuant to the terms and conditions of the Rights Issue as set out in the Prospectus. By signing and returning the Letter of Confirmation a Placee undertakes and agrees, following the acquisition of Placing Shares in the amount of its Placing Participation, to take up in full the rights to Rights Issue Shares relating to its Placing Shares pursuant to the proposed Rights Issue on the terms and conditions set out in the Prospectus. Nil Paid Rights in respect of the relevant Rights Issue Shares will be distributed to the Placee's CREST account automatically through the CREST market claims mechanism. In this Appendix, unless the context otherwise requires, "Placee" means a person (including individuals, funds or others) by whom or on whose behalf a commitment to subscribe for Placing Shares has been given. Application for listing and admission to trading Application will be made to the Financial Services Authority (the "FSA") for admission of the Placing Shares to the Official List of the FSA (the "Official List") and to the London Stock Exchange plc for admission to trading of the Placing Shares on its market for listed securities (together, "Placing Admission"). It is expected that Placing Admission will become effective on 23 November 2009 and that dealings in the Placing Shares will commence at that time. RBS Hoare Govett will today commence the bookbuilding process in respect to the Placing (the "Bookbuild") to determine demand for participation in the Placing by Placees. This Appendix gives details of the terms and conditions of, and the mechanics of participation in, the Placing. RBS Hoare Govett and the Company shall be entitled to effect the Placing by such alternative method to the Bookbuild as they may, in their absolute discretion, determine.
Participation in, and principal terms of, the Placing
bookrunner of the Company. 2 Unless RBS Hoare Govett, in its absolute discretion, agrees otherwise, participation in the Placing will be available only to persons who may lawfully be, and are, invited to participate by RBS Hoare Govett and who execute a placing letter prior to Placing Admission (the "Placing Letter"). RBS Hoare Govett and its affiliates are entitled to enter bids
in the Bookbuild as principal.
discretion agrees otherwise, Placees shall communicate their bid by telephone to their usual sales contact at RBS Hoare Govett (provided that they subsequently execute and return the Letter of Confirmation (as defined below) no later than 5 p.m. on 29 October 2009). Each bid should state the number of Placing Shares which the prospective Placee wishes to
subscribe for.
October 2009 but may be closed earlier or later at the discretion of RBS Hoare Govett. RBS Hoare Govett may, in agreement with the Company, accept bids that are received after the Bookbuild has closed. The Company and RBS Hoare Govett reserve the right to reduce or seek to increase the amount to be raised pursuant to the Placing, in their absolute
discretion.
Placing Letter in respect of such allocation will be sent to such Placee, by RBS Hoare Govett following the closing of the Bookbuild. RBS Hoare Govett reserves the right to reject or scale back bids from prospective Placees following consultation with the Company. Upon receipt of a letter of confirmation from a Placee by RBS Hoare Govett in the form set out in the schedule to the Placing Letter (a "Letter of Confirmation"), RBS Hoare Govett's oral confirmation to such Placee will constitute an irrevocable legally binding commitment upon such person (who will at that point become a Placee) in favour of each of RBS Hoare Govett and the Company, under which it agrees to subscribe for the number of Placing Shares set out in its Letter of Confirmation and allocated to it at the Placing Price on the terms and conditions set out in this Appendix and in accordance with the Company's Memorandum and Articles of Association. On the second Business Day following (and subject to) the passing of the shareholders' resolutions to be proposed at a general meeting of the Company in connection with the Placing and Rights Issue (the "Resolutions") (the "GM") which is expected to be held on 20 November 2009, a trade confirmation will be dispatched, in accordance with standing arrangements. The terms of this Appendix will be deemed to be
incorporated by reference therein.
the terms and subject to the conditions in this Announcement (including this Appendix) and, unless RBS Hoare Govett, in its absolute discretion, agrees otherwise, will be legally binding on the Placee on behalf of which it is made and except with RBS Hoare Govett's consent will not be capable of variation or revocation by the Placee after the time at which the Letter of Confirmation is submitted. Each Placee will also have an immediate, separate, irrevocable and binding obligation, owed to RBS Hoare Govett, to pay to RBS Hoare Govett (or as RBS Hoare Govett may direct) in cleared funds an amount equal to the product of the Placing Price and the number of Placing Shares such Placee has agreed to
subscribe.
Placing is confirmed, settlement for all Placing Shares to be acquired pursuant to the Placing will be required to be made at the same time, on the basis explained below under "Registration and Settlement" and in each
Placee's Placing Letter.
fulfilment of the conditions referred to below under "Conditions of the Placing" and to the Placing not being terminated on the basis referred to
below under "Right to terminate under the Underwriting Agreement".
each Placee will agree that its rights and obligations in respect of the Placing will terminate only in the circumstances described below and will not be capable of rescission or termination by the Placee at any time on or after Placing Admission. 10 To the fullest extent permissible by law, neither the Banks nor any of their affiliates shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, neither RBS Hoare Govett nor any of its affiliates shall have any liability (including to the extent permissible by law, any fiduciary duties) in respect of RBS Hoare Govett's conduct of the Bookbuild (including acceptance or rejection of any bid) or of such alternative method of effecting the Placing as RBS Hoare Govett and the Company may agree. Conditions of the Placing
Each of the Bank's obligations under the Underwriting Agreement in respect of the Placing Shares are conditional on, inter alia:
(a) the release of the Press Announcement in accordance with the
(b) the formal approval by the FSA of the Prospectus by not later than 5
(c) the posting of the Prospectus, Form of Proxy and Provisional Allotment
(d) the passing of the Resolutions (or with such amendments as the Banks may
(e) none of the warranties and undertakings on the part of the Company
(f) the New Facilities Agreements (as defined in the Underwriting Agreement)
(g) no matter having arisen prior to the time of Admission which might
(h) the Company not being in breach of any of its obligations under the
(i) to the extent that they are required to be delivered prior to Admission
(j) the delivery by the Company immediately prior to Admission to the Banks
(k) no event referred to in section 87G of the FSMA arising between the time
(l) the Company having applied to Euroclear for admission of the Nil-paid
(m) there not having occurred in the opinion of any of the Banks any
(n) Admission taking place by no later than 8.00 a.m. on the first Dealing
If: (i) any of the conditions contained in the Underwriting Agreement in relation to the Placing Shares are not fulfilled or, where relevant, waived by the Banks at their absolute discretion by the respective time and/or date where specified; or (ii) the Underwriting Agreement is terminated in the circumstances specified below, the Placing will lapse and the Placee's rights and obligations hereunder in relation to the Placing Shares shall cease and terminate at such time and each Placee agrees that no claim can be made by the Placee (or any person on whose behalf a Placee is acting) in respect thereof. The Banks may, at their absolute discretion and upon such terms as they think fit, waive compliance by the Company, or extend the time and/or date for fulfilment by the Company, with the whole or any part of any of the Company's obligations in relation to the conditions in the Underwriting Agreement, save that certain of the conditions, including the above condition relating to Placing Admission occurring, may not be waived. Any such extension or waiver will not affect Placees' commitments as set out in this Announcement. None of the Banks, the Company or any of their respective affiliates or any other persons shall have any liability to any Placee (or to any other person whether acting on behalf of a Placee or otherwise) in respect of any decision it may make as to whether or not to waive or to extend the time and/or date for the satisfaction of any condition to the Placing nor for any decision they may make as to the satisfaction of any condition or in respect of the lacing generally and by participating in the Placing each Placee agrees that any such decision is within the absolute discretion of either of the Banks or the Company. Right to terminate under the Placing Agreement
Either of the Banks may, at its absolute discretion (acting in good faith), at any time before Admission, terminate the Underwriting Agreement by giving notice to the Company if, inter alia:
(a) any statement contained in the Prospectus, the Press Announcement, the Provisional Allotment Letter, or
(b) any matter has arisen or been discovered which would, if the Disclosure Documents were to be issued at
(c) the Company fails to comply with any of its obligations under the Underwriting Agreement or certain other
(d) there has been a breach by the Company of any of the warranties or undertakings contained in or given
(e) an event has occurred or matter arisen on or after the date of the Underwriting Agreement and before
(f) any matter or circumstance has arisen prior to the time of Admission which might reasonably be expected
(g) there shall has been a Material Adverse Change (whether or not foreseeable at the date of the
(h) there has occurred or, in the opinion of either of the Banks it is reasonably likely that there will
(i) the Company's application to the FSA for Placing Admission and/or Rights Issue Admission (as such terms
If the Underwriting Agreement is terminated in accordance with its terms, the rights and obligations of each Placee in respect of the Placing as described in this Announcement shall cease and terminate at such time and no claim can be made by any Placee in respect thereof pursuant to the Placing Letter or howsoever otherwise. By participating in the Placing, Placees agree that the exercise by either of the Banks of any right of termination or other rights or discretions under the Underwriting Agreement or the Placing and Rights Issue shall be within the absolute discretion of the Banks and that they need not make any reference to Placees pursuant to the Placing Letter or otherwise and that neither of the Banks shall have any liability to Placees whatsoever in connection with any such exercise or the timing thereof. The Placees further agree that neither of the Banks owes any fiduciary duty or other duty to any Placee in respect of any warranties, undertakings or indemnities in the Underwriting Agreement. The Prospectus A document comprising a prospectus prepared in accordance with the Prospectus Rules relating to the Company, the Placing and the Rights Issue which gives details, inter alia, of the Placing and a circular to Shareholders containing the notice of the GM, is expected to be published in the first week of November 2009. Each Placee, by accepting a participation in the Placing and/or by sending its Letter of Confirmation to RBS Hoare Govett, agrees that the content of this Announcement is exclusively the responsibility of the Company and confirms that it has neither received nor relied (nor will rely) on any other information, representation, warranty, or statement made by or on behalf of the Company or either of the Banks or any other person and non of the Banks, nor the Company, or any of their respective affiliates, or any other person will be liable for any Placee's decision to participate in the Placing based on any other information, representation, warranty or statement which the Placees may have obtained or received. Each Placee acknowledges and agrees that it has relied on its own investigation of the business, financial or other position of the Company in deciding whether or not to participate in the Bookbuild process and, if relevant, to accept a participation in the Placing. Nothing in this paragraph shall exclude the liability of any person for fraudulent misrepresentation. Registration and Settlement Settlement of transactions in the Placing Shares (ISIN: GB00B01DW905) following Placing Admission is expected to take place within the CREST system. Settlement will be on a delivery versus payment basis. However, in the event of any difficulties or delays in admission of the Placing Shares to CREST or the use of CREST in relation to the Placing, the Company and RBS Hoare Govett may agree that the Placing Shares should be issued in certificated form. RBS Hoare Govett reserves the right to require settlement for and delivery of the Placing Shares to Placees by such other means that it deems necessary if delivery or settlement is not possible or practicable within the CREST system within the timetable set out in this Announcement or would not be consistent with the regulatory requirements in the Placee's jurisdiction. Each Placee who has been allocated Placing Shares in the Placing will, two Business Days after the GM, be sent a trade confirmation by RBS Hoare Govett (who shall be conditionally allotted such Placing Shares by the Company as nominee for the Placees upon such date) pursuant to its Placing Letter stating the number of Placing Shares allocated to it at the Placing Price, the aggregate amount owed by such Placee to RBS Hoare Govett and settlement instructions. Each Placee agrees that it will do all things necessary to ensure that delivery and payment is completed in accordance with either the standing CREST or certificated settlement instructions that it has in place with RBS Hoare Govett. It is expected that settlement between the Placees and RBS Hoare Govett will be on a T+3 basis (where T is the date that is two Business Days following the GM) unless otherwise notified by RBS Hoare Govett in accordance with the terms of the Placing Letter and the instructions set out in the trade note or confirmation. Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of 2 percentage points above LIBOR as determined by RBS Hoare Govett. Each Placee is deemed to agree that if it does not comply with these obligations, the beneficial ownership of the Placing Shares allocated to such Placee shall be transferred from such Placee to RBS Hoare Govett and RBS Hoare Govett shall hold the legal title of such Placing Shares from the time of such Placee's default and accordingly RBS Hoare Govett may sell any or all of such Placing Shares. If the proceeds of such Placing Shares are less than the aggregate amount owed by the relevant Placee plus any interest due, the relevant Placee will, however, remain liable for the shortfall and may be required to bear any stamp duty or stamp duty reserve tax (together with any interest or penalties) which may arise upon the sale of such Placing Shares by RBS Hoare Govett. If Placing Shares are to be delivered to a custodian or settlement agent, Placees should ensure that the commission payment instruction form (appended to the Placing Letter) is completed by such custodian or settlement agent and returned to RBS Hoare Govett by 5 p.m. on 29 October 2009 and that the trade confirmation is copied and delivered immediately to the relevant person within that organisation. Insofar as Placing Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Placing Shares should, subject as provided below, be so registered free from any liability to UK stamp duty or UK stamp duty reserve tax. Placees will not be entitled to receive any fee or commission in connection with the Placing. Representations and Warranties
By participating in the Bookbuild process and the Placing each Placee (and any person acting on such Placee's behalf) will give representations and warranties to each of the Banks that it:
entirety and that its acquisition of Placing Shares is subject to and based upon all the terms, conditions, representations, warranties, acknowledgements, agreements and undertakings and other information
contained herein and in the Placing Letter;
connection with the Placing as at the date of this Announcement and represents and warrants that it has not received a prospectus or other offering document in connection therewith as at the date of this
Announcement;
representation in relation to the Company or its affiliates or the Placing Shares other than as contained in the Press Announcement, and (ii) none of the Company, the Banks, their respective directors, officers, employees, agents representatives subsidiaries or affiliates (or any of them) or any person acting on behalf of any them shall have any liability for any other information, representation or warranty, provided that nothing in this paragraph shall exclude the liability of
any person for any fraudulent misrepresentation made by that person;
to, or in relation to, and no responsibility or liability will be accepted by either of the Banks or any of their respective employees, affiliates, advisers or agents or any other person as to, or in relation to, the Press Announcement or the Prospectus or any other written or oral information made available to or publicly available to it (including the Placing Letter), any person acting on its behalf or any of its or their advisers of any of them, and any liability therefore is expressly
disclaimed;
it has knowledge and experience in financial, business and international investment matters as is required to evaluate the merits and risks of subscribing for or purchasing the Placing Shares. It further confirms that it is experienced in investing in securities of this nature in this sector and is aware that it may be required to bear, and is able to bear, the economic risk of, and is able to sustain a complete loss in connection with the Placing. It further confirms that it relied on its own examination and due diligence of the Company and its associates taken as a whole, and the terms of the Placing, including the merits and risks
involved;
satisfied itself concerning legal, regulatory, tax, business and financial considerations in connection herewith to the extent it deems necessary; (b) had access to review publicly available information concerning the Company that it considers necessary or appropriate and sufficient in making an investment decision; (c) reviewed such information as it believes is necessary or appropriate in connection with its subscription for the Placing Shares; and (d) made its investment decision based upon its own judgement, due diligence and analysis and not upon any view expressed or information provided by or on behalf of the
Banks;
Banks or any person acting on its behalf may or may not have conducted with respect to the Company, its group, or the Placing and the Banks have not made any representation to it, express or implied, with respect to the merits of the Placing, the subscription for the Placing Shares, or as to the condition, financial or otherwise, of the Company, its group, or as to any other matter relating thereto, and nothing herein shall be construed as a recommendation to it to subscribe for the Placing Shares. It acknowledges and agrees that no information has been prepared by the
Banks or the Company for the purposes of this Placing;
neither of the Banks is making any recommendations to or advising it regarding the suitability or merits of any transaction it may enter into in connection with the Placing, the Rights issue or otherwise and that it is not, and does not regard itself as, a client of either of the Banks in connection with the Placing and/or the Rights Issue, and that the Banks are acting solely for the Company in relation to the Placing and the Rights Issue and will not regard any other person as their client in relation to the Placing and Rights Issue and will not be responsible to it for providing the protections afforded to their clients or for
advising it on the Placing and or the Rights Issue;
applicable legal and regulatory provisions, engage in transactions in relation to the ordinary shares of the Company and/or related instruments for their own account or otherwise and, except as required by applicable law or regulation, the Banks will not make any public disclosure in relation to such transactions; 10 acknowledges, undertakes and agrees with each of the Banks and the Company that where it is a related party of the Company for the purposes of the Listing Rules that (a) the acquisition of the Placing Shares comprised in its Placing Participation as provided for herein shall be conditional upon the approval of the Resolution at the EGM in relation to its subscription for such Placing Shares in the Placing, (b) it will not vote on such Resolution and will take all reasonable steps to ensure that its associates do not vote on such Resolution and (c) it will provide all information requested by either of the Banks or the Company for the purposes of completing the disclosure in the Prospectus in relation to it and its associates as required by the Listing Rules and the Prospectus Rules; 11 (a) is duly incorporated and validly existing under the laws of its jurisdiction of incorporation; (b) has power under its constitutional documents and has obtained all necessary authorities (including, without limitation, all relevant members' resolutions) to acquire and pay for the Placing Shares in the manner proposed and to enter into and perform its obligations pursuant to the Placing Letter and the Letter of Confirmation; (c) there are no governmental or regulatory consents or other third party approvals, authorisations or orders required (including, without limitation, any consent of the Board of Governors of the U.S. Federal Reserve System) in order for it to acquire and pay for the Placing Shares in the manner proposed and to enter into and perform it obligations pursuant to the Placing Letter and the Letter of Confirmation that have not been or will not prior to the issue of the Placing Shares have been obtained. It represents and warrants that it has complied and will comply with all applicable provisions of the Financial Services and Markets Act 2000 (the "FSMA") with respect to anything done by it in relation to the Placing Shares in, from or otherwise involving the United Kingdom. It undertakes that it will not make any offer to the public of the Placing Shares comprised within its Placing Participation for the purposes of the Prospectus Rules made by the Financial Services Authority pursuant to Commission Regulation (EC) No. 809/2004; 12 the entering into of the agreement constituted by the telephone conversation referred to above, the Placing Letter and the Letter of Confirmation and performance of its obligations pursuant thereto and the acquisition of and payment for the Placing Shares will comply with all agreements to which it is a party or by which it or any of its properties or assets are bound and which is material to its participation and its obligations in respect thereof. The Letter of Confirmation will have been duly authorised, executed and delivered by it and the agreement constituted by its telephone conversation, this Placing Letter and the Letter of Confirmation constitutes the valid and legally binding agreement; 13 has funds available to pay to RBS Hoare Govett the full amounts referred to in and pursuant to the Placing Letter as and when due; 14 acknowledges and agrees that the Placing Shares are being offered and sold to it pursuant to Regulation S in a transaction not involving a public offering of securities in the United States and the Placing Shares have not been and will not be registered under the Securities Act. It acknowledges that the Placing Shares may not be offered, sold, pledged, resold, transferred, delivered or distributed within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act; 15 was outside of the United States during any offer or sale of the Placing Shares to it and it is acquiring the Placing Shares in an "offshore transaction" (within the meaning of Regulation S); 16 understands and agrees that if in the future it decides to dispose of any of the Placing Shares, it may do so only in compliance with the Securities Act and applicable state securities laws and the securities laws of any other relevant jurisdiction, as then in effect; 17 is acquiring the Placing Shares for its own account (or for the account of its affiliates or funds managed by it or its affiliates with respect to which it has investment discretion), not with a view to, or for resale in connection with, the distribution thereof or the distribution of the Placing Shares, into the United States. It represents and warrants that, if it is acquiring Placing Shares for one or more managed accounts, it is authorised in writing by each managed account to acquire such Placing Shares on their behalf; 18 is not resident or domiciled in or a national of the United States or any of the Excluded Territories nor is it acquiring the Placing Shares for the benefit of such a person or with a view to resale to such a person; 19 warrants that (i) it is a person whose ordinary activities involve it in acquiring, holding, managing or disposing of investments (as principal or agent) in the course of its business and a qualified investor within the meaning of section 85(7) of the FSMA, (ii) if in the UK, it is a person of a kind described in articles 19(5) or 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended), (iii) if it is a resident in the EEA, it is a 'Qualified Investor' within the meaning of the law in the Relevant Member State implementing Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC); and (iv) it does not intend to offer or sell or otherwise deal with the Placing Shares in any way which would result in an offer to the public in the UK within the meaning of the FSMA or in any other jurisdiction or require registration or prospectus publication or similar actions in the UK or any other jurisdiction; 20 is aware of, has complied with and will continue to comply with any obligations it has under the Criminal Justice Act 1993, section 118 of the FSMA and the Proceeds of Crime Act 2002 to the extent applicable to it. It is also aware of its obligations in connection with money laundering under the Proceeds of Crime Act 2002 and it complied with the Money Laundering Regulations 1993, 2003 and 2007 and, if it is making payment on behalf of a third party, it has obtained and recorded satisfactory evidence to verify the identity of the third party as required by relevant law and regulations; 21 represents and warrants that it is not acting in concert (within the meaning given in the City Code on Takeovers and Mergers) with any other Placee or any other person in relation to the Company; 22 to the fullest extent permitted by law, it acknowledges and agrees to the disclaimers contained in the Press Announcement; 23 warrants that it is a sophisticated investor with knowledge and experience in financial and business matters, including but not limited to sales and purchases of securities, as to be capable of evaluating the merits and risks of the Placing Shares; 24 warrants that it has independently, without reliance upon any other party and based on such information it has deemed appropriate in your independent judgment, made its own analysis and decision with respect to its investment in the Placing Shares; 25 represents and warrants that it is not a person whose business is or includes, issuing depository receipts or a person whose business is, or includes, the provision of clearance services for the purchase or sale of securities or a nominee of any such person; 26 has made its own independent investigation and appraisal of the business, results, financial condition, prospects, creditworthiness, status and affairs of the Company and it has made its own investment decision to acquire the Placing Shares; 27 has read, agreed with, understood and accepted the terms and conditions of this letter and the Press Announcement and, accordingly, to have irrevocably agreed in accordance with such terms and conditions to acquire and pay for the number of Placing Shares comprised in its Placing Participation and its related rights under the Rights Issue in full; 28 acknowledges that neither the Company nor any of its affiliates nor any other person (including the Banks or any of their affiliates) has made any representations, express or implied, to it with respect to the Company, the Placing Shares or the accuracy, completeness or adequacy of any financial or other information concerning the Company or the Placing Shares, other than (in the case of the Company and its affiliates only) the information contained or incorporated by reference in the Press Announcement. It acknowledges that it has not relied on any information contained in any research reports prepared by the Banks or any of their respective affiliates; 29 declares that sections 67, 70, 93 and 96 of the Finance Act 1986 (depositary receipts and clearance services) do not apply on your acquisition of Placing Shares (or that if this is not applicable it has informed us in writing of its status for stamp duty and stamp duty reserve tax purposes); 30 acknowledges that any agreements entered into by it pursuant to these terms and conditions, including any non-contractual obligations arising out of or in connection with these terms and conditions, shall be governed by and construed in accordance with the laws of England and Wales and it submits (on behalf of itself and on behalf of any person on whose behalf it is acting) to the exclusive jurisdiction of the English courts as regards any claim, dispute or matter arising out of any such contract or non-contractual obligation, except that enforcement proceedings in respect of the obligation to make payment for the Placing Shares (together with any interest chargeable thereon) may be taken by the Company or any of the Banks in any jurisdiction in which the relevant Placee is incorporated or in which any of its securities have a quotation on a recognised stock exchange; 31 agrees that the Company, the Banks and their respective affiliates and others will rely upon the truth and accuracy of the foregoing representations, warranties, acknowledgements and undertakings which are given to each of the Banks on its own behalf and on behalf of the Company and are irrevocable; 32 acknowledges that time shall be of the essence as regards obligations pursuant to this Announcement; and 33 agrees to indemnify on an after-tax basis and hold the Company, each of the Banks and their respective affiliates harmless, on an after-tax basis, from any and all costs, claims, liabilities, losses and expenses (including legal fees and expenses) arising out of or in connection with any breach of the representations, warranties, acknowledgements, agreements and undertakings in this Appendix and further agrees that the provisions of this Appendix shall survive after completion of the Placing. The above representations, warranties and undertakings are incorporated by reference into the Placing Letter and in the event of any inconsistency between the representations, warranties and undertakings set out in this Appendix and those set out in the Placing Letter, the representations, warranties and undertakings set out herein shall take precedence and prevail. The agreement to settle a Placee's Placing Participation (and/or the participation of a person for whom such Placee is contracting as agent) free of UK stamp duty and UK stamp duty reserve tax depends on the settlement relating only to subscription by it and/or such person direct from the Company or from RBS Hoare Govett (as nominee or agent for the Placees) for the Placing Shares in question. Such agreement assumes that the Placing Shares are not being subscribed to or purchased for in connection with arrangements to issue depositary receipts or to transfer the Placing Shares into a clearance service. If there are any such arrangements, or the settlement relates to any other dealing in the Placing Shares, UK stamp duty or UK stamp duty reserve tax may be payable, for which neither the Company nor RBS Hoare Govett will be responsible. If this is the case, the relevant Placee should seek its own advice and notify RBS Hoare Govett accordingly. In addition, Placees should note that they will be liable for any UK stamp duty and UK stamp duty reserve tax and all other stamp, issue, securities, transfer, registration, documentary or other duties or taxes (including any interest, fines or penalties relating thereto) payable outside the UK by them or any other person on the acquisition by them of any Placing Shares or the agreement by them to subscribe for any Placing Shares. Each Placee and any person acting on behalf of the Placee acknowledges and agrees that either Bank or any of their affiliates may, at its absolute discretion, agree to become a Placee in respect of some or all of the Placing Shares. When a Placee or person acting on behalf of the Placee is dealing with RBS Hoare Govett, any money held in an account with RBS Hoare Govett on behalf of the Placee and/or any person acting on behalf of the Placee will not be treated as client money within the meaning of the rules and regulations of the FSA made under the FSMA. The Placee acknowledges that the money will not be subject to the protections conferred by the client money rules; as a consequence, this money will not be segregated from RBS Hoare Govett's money in accordance with the client money rules and will be used by RBS Hoare Govett in the course of its own business; and the Placee will rank only as a general creditor of RBS Hoare Govett. All times and dates in this Announcement may be subject to amendment. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. For the avoidance of doubt, the commitments, representations, warranties and undertakings of any Placee under the Placing are not conditional on any of the expected dates in this Announcement actually being achieved. RBS Hoare Govett shall notify the Placees and any person acting on behalf of the Placees of any changes. 10. General The Prospectus will give further details of the Firm Placed Shares, the Nil Paid Rights, the Fully Paid Rights and the New Shares (together "the Securities") to be offered pursuant to the Firm Placing and the Rights Issue. A copy of the Prospectus when published will be available from the registered office of e2v at 106 Waterhouse Lane, Chelmsford, Essex CM1 2QU during usual business hours on any weekday (Saturdays, Sundays and Bank Holidays excepted) and from the offices of Macfarlanes LLP, 20 Cursitor Street, London EC4A 1LT. The Prospectus will also be available on the Company's website, www.e2v.com This announcement is not a prospectus but an advertisement and investors should not subscribe for any Securities referred to in this announcement except on the basis of the information contained in the Prospectus. This announcement does not constitute an offer to sell, or a solicitation of an offer to subscribe for any Securities being issued in connection with the Firm Placing and the Rights Issue, in any jurisdiction in which such offer or solicitation is unlawful. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, New Zealand, South Africa or Switzerland or any other jurisdiction where the same would be unlawful. This announcement does not constitute, or form a part of, any offer or solicitation to purchase or subscribe for securities in the United States. The Securities have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of any of the Securities in the United States. The Securities have not been approved or disapproved by the US Securities and Exchange Commission, any state's securities commission in the United States or any other US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Securities or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence. The Securities will not be registered under the securities laws of Australia, Canada, Japan, New Zealand, South Africa or Switzerland and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within such jurisdictions except pursuant to an applicable exemption from and in compliance with any applicable securities laws. There will be no public offer in any of Australia, Canada, Japan, New Zealand, Switzerland or South Africa. Rothschild and RBS Hoare Govett , each of which is authorised and regulated in the United Kingdom by the FSA, are acting exclusively for the Company and no one else in connection with the Firm Placing and the Rights Issue and Admission and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Firm Placing and the Rights Issue and Admission and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Firm Placing and the Rights Issue and admission or any matters referred to in this announcement. This announcement has been issued by and is the sole responsibility of the Company. None of Rothschild nor RBS Hoare Govett (or any of their respective affiliates or agents) accept any responsibility whatsoever for, and make no representation or warranty, express or implied, in relation to, the contents of this announcement (including its accuracy, completeness or verification) or any other statement made or purported to be made by them, or on their behalf, in connection with the Company, the Firm Placed Shares, the Firm Placing, the Nil Paid Rights, the Fully Paid Rights, the New Shares or the Rights Issue. Each of Rothschild and RBS Hoare Govett accordingly disclaims to the fullest extent permitted by law all and any responsibility and liability, whether arising in tort, contract or otherwise in respect of this announcement or any such statement. Neither the content of e2v's website nor any website accessible by hyperlinks on e2v's website is incorporated in, or forms part of, this announcement. The distribution of this announcement and/or the Prospectus and/or the Provisional Allotment Letters and/or the transfer of Securities into jurisdictions other than the United Kingdom may be restricted by law. No action has been taken by the Company or any of Rothschild or RBS Hoare Govett that would permit an offering of such rights or shares or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement contains certain forward-looking statements which may include reference to one or more of the following: the Group's financial condition, results of operations, cashflows, dividends, financing plans, business strategies, operating efficiencies or synergies, budgets, capital and other expenditure, competitive positions, growth opportunities for existing products, sales, prices of products, plans and objectives of management and other matters. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "plans", "annualised", "goal", "target", "aim", "may", "will", "would", "could" or "should" (or in each case, their negative or other variations or comparable terminology). Statements in this announcement that are not historical facts are hereby identified as "forward-looking statements". Such forward-looking statements, including, without limitation, those relating to future business prospects, revenue, liquidity, capital needs, expected cost savings, interest costs and income, in each case relating to e2v, wherever they occur in this announcement, are not necessarily based on assumptions reflecting the views of e2v and involve a number of known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements. Such forward-looking statements should, therefore, be considered in the light of various important factors. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, without limitation: economic and business cycles, the terms and conditions of e2v's financing arrangements, including fluctuations in interest rates, foreign currency rate fluctuations, competition in e2v's principal markets, acquisitions or disposals of businesses or assets and trends in e2v's principal industries and markets and the impact of the acceleration of the Group's "Fit for the Future" restructuring programme. These forward-looking statements are not guarantees of future performance. Rather, they are based on current views and assumptions and involve known and unknown risks, uncertainties and other factors, many of which are outside the control of the Company and are difficult to predict, that may cause actual results to differ materially from any future results or developments expressed or implied from the forward-looking statements. These forward-looking statements speak only as of the date of this announcement. The information and opinions contained in this announcement are subject to change without notice and, subject to any obligations under the Prospectus Rules, Listing Rules or the Disclosure and Transparency Rules, and save as required by law, e2v assumes no responsibility or obligation to update publicly or review any of the forward-looking statements contained herein and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained herein to reflect any change in e2v's expectations with regard thereto or any change in events, conditions or circumstances on which such statement is based. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. No statement in this announcement is intended to be a profit forecast.
DEFINITIONS The following definitions apply throughout this announcement, unless the context requires otherwise:
Agreement"
"Existing Lending Facilities" the lending facilities provided under the Existing Facility
"LSE"
"Memorandum of Association" or the memorandum of association of the Company
"Memorandum"
"Provisional Allotment Letter" the renounceable provisional allotment letter expected to be
End This information is provided by RNS The company news service from the London Stock Exchange END
IOEEAXENAEANFEE More |
||
| 09-10-09 | RNS |
|
|
RNS Number : 5049A e2v technologies PLC 09 October 2009 9th October 2009 e2v technologies plc Period End Update e2v technologies plc, the specialist developer and manufacturer of high technology components and sub-systems, is providing its regular period end update ahead of its half year results announcement for the six months ended 30 September 2009. Group trading has continued in line with management expectations reflecting lower demand, the impact of which has been partially offset by cost reductions, particularly in the second quarter. As expected, activity in the Electron Devices and Subsystems division has continued to be significantly lower than last year, reflecting reduced demand for new systems in the medical and industrial markets and lower activity in defence. This has been partly offset by continuing demand for spares, particularly in medical. Within Imaging, demand from the dental and industrial markets, which are primarily serviced by our French operations, has continued to decline significantly. This has been partly offset by increased activity associated with space related applications. Specialist Semiconductors has grown, reflecting the acquisition of QP Semiconductors, and whilst underlying demand has declined, it has held up comparatively well in the current environment. Our smallest division, Sensors, has achieved encouraging comparative period growth, across its portfolio of businesses as a whole. The order book at 30 September 2009 was slightly over £130m (2008: £118m) and whilst management expect revenue for the full year to remain materially second half weighted, this is supported by higher levels of order cover for the second half, when compared with last year. As at 30 September 2009 net borrowings were approximately £105m, a £32m reduction from 31 March 2009. Approximately £20m of this reduction was from operating cash flow with the balance due to currency, benefiting from conversion of the group's euro denominated debt to sterling in the half year. Good progress is being made in reviewing the appropriate scale of operations to support the anticipated level of sustainable demand. The Board anticipates that trading in the first half has met the levels necessary for the business to operate within the financial covenants in its debt facilities. The company announced on 30 September 2009 that it had agreed an amended facility, including a waiver of the September covenant tests, which has enabled the Board to progress key terms with its debt providers as part of the continuing process of preparing for a future increase in equity capital. On 25 September we announced the appointment of our new Chairman, Chris Geoghegan. For further information:
Keith Attwood/Charles Hindson www.e2v.com
Jon Simmons/Sophie Kernon
NOTES FOR EDITORS e2v e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets. e2v is organised into four divisions:
For the year ended 31 March 2009, e2v achieved sales of £233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. The Company is headquartered in the United Kingdom and has approximately 1700 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers. Further information is available from www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange END
MSCGGMGGGRLGLZZ More |
||
| 07-10-09 | RNS |
|
|
RNS Number : 3884A e2v technologies PLC 07 October 2009 7 October 2009 e2v technologies plc Total Voting Rights In conformity with the Transparency Directive's transitional provision 6, the Company would like to notify the market of the following: The Company's issued share capital consists of 62,569,593 Ordinary Shares of 5p each with one voting right per share. The total number of shares in the Company with voting rights is therefore 62,569,593. The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. This information is provided by RNS The company news service from the London Stock Exchange END
TVREAEEXELNNFFE More |
||
| 30-09-09 | AFX UK Focus |
|
|
LONDON, Sept 30 (Reuters) - E2V Technologies Plc:
((London Equities Newsroom; +44 20 7542 7717)) (For more news, please click here)
COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. More |
||
| 30-09-09 | RNS |
|
|
RNS Number : 9260Z e2v technologies PLC 30 September 2009
30 September 2009 e2v technologies plc Amendment to debt facilities e2v technologies plc, the specialist developer and manufacturer of high technology components and sub-systems, announces that it has today entered into a waiver and amendment of its existing debt facilities. As previously announced, e2v has been working with its financial advisors to review a range of options for the most appropriate long term capital structure for the Group. As part of this review, e2v has held discussions with its debt providers and has today entered into a waiver and amendment agreement to its current facilities agreement. The waiver relates to the testing of its financial covenants under the facilities agreement, due on 30 September 2009, which will no longer take place. The amendments to the facilities agreement incur a fee, payable by e2v to the debt providers, of 75 basis points on a revised facilities amount of £150m and include an additional covenant test due on 30 November 2009. The term of the facilities agreement remains unchanged at 12 July 2011. Although it is anticipated that the financial covenants, due to be tested on 30 September 2009, would not have been breached, the waiver and amendment agreement provides certainty and has enabled the Board to progress key terms with debt providers for the long term capital structure for the Group. The additional covenant test, due on 30 November 2009, will include the benefit of proceeds arising from any potential equity capital raising, provided that it has been both fully underwritten and approved by shareholders by 30 November 2009. Preparations are now underway for a potential equity capital raising by the Company to meet this timetable. e2v will release a period end trading update for the six months ended 30 September 2009 in due course. Further enquiries:
e2v technologies plc
Charles Hindson, Group Finance Director
Website: www.e2v.com
Financial Dynamics
NOTES FOR EDITORS e2v e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets. e2v is organised into four divisions:
For the year ended 31 March 2009, e2v achieved sales of £233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. The Company is headquartered in the United Kingdom and has approximately 1700 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers. Further information is available from www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange END
MSCWUUQCBUPBUAU More |
||
| 25-09-09 | RNS |
|
|
RNS Number : 6503Z e2v technologies PLC 25 September 2009 25 September 2009 e2v technologies plc Appointment of New Chairman e2v technologies plc, a leading developer and manufacturer of high-technology electronic components and sub-systems to the aerospace & defence, medical & science, and commercial & industrial sectors, is pleased to announce the appointment of Chris Geoghegan as its new Non-Executive Chairman with effect from 1st October 2009. Mr Geoghegan has considerable experience of e2v's major markets and has also been highly influential in the successful implementation of business improvement programmes in the geographies in which e2v operates. Mr Geoghegan, a former group executive director of BAE Systems plc, is the Chairman of Hampson Industries plc, senior independent director of both Kier Group plc and Volex plc and a non executive director of SIG plc. In June 2009, e2v announced the planned retirement of Mr George M Kennedy CBE as Chairman. Mr Kennedy will step down from the Board after a short handover period. Mr Kennedy commented: "e2v has made substantial progress in recent years and I am pleased to have contributed to its success. The Board's succession planning has worked well, with a new Finance Director in place, and now the seamless appointment of Mr Chris Geoghegan as my successor. Chris brings extensive experience of the aerospace and defence industries to the Board and will help take e2v to the next level." Mr Geoghegan, the Chairman elect of e2v commented: "I am very pleased to be joining the Board of e2v. I have every confidence in the ability of the Group to create considerable value for shareholders in the medium term. I look forward to working with the management team to chart the future direction of e2v." Chris Geoghegan biography: Mr Geoghegan was a group executive director of BAE Systems plc from 2002 until 2007 and a past president of the Society of British Aerospace Companies. He has over 30 years' experience in the aerospace industry having spent most of his career in the commercial aircraft sector and was appointed one of three chief operating officers of BAE Systems plc. From 2000 to 2002, following the merger of British Aerospace and Marconi Electronics Systems, he was group managing director of the combined Avionics Group. Mr Geoghegan was a key player in the growth and establishment of Airbus as managing director of the Airbus Company and a member of the executive board of Airbus Industrie. He also has substantial experience in the military aerospace sector, having been responsible for BAE Systems' European Defence joint ventures and its Defence Electronics companies. Mr Geoghegan began his career in 1972 at Hawker Siddeley which later formed part of British Aerospace where he worked in sales contracts, purchasing, production, site management and operations. He is currently the Chairman of Hampson Industries plc, senior independent director of both Kier Group plc and Volex plc and a non-executive director of SIG plc. There are no further details requiring disclosure under Listing Rule 9.6.13. Further enquiries:
e2v technologies plc
Charles Hindson, Group Finance Director
Website: www.e2v.com
Financial Dynamics
NOTES FOR EDITORS e2v e2v's objective is to be a global leader in the design and supply of specialised components and sub-systems that enable the world's leading systems companies to deliver innovative solutions for medical & science, aerospace & defence, and commercial & industrial markets. e2v is organised into four divisions:
For the year ended 31 March 2009, e2v achieved sales of £233m and is listed on the London Stock Exchange. In October 2008 e2v acquired QP semiconductor, a leading US-based designer and supplier of specialty semiconductor components used in military and aerospace applications, establishing e2v's first US manufacturing base. The Company is headquartered in the United Kingdom and has approximately 1700 employees in six production facilities across Europe and North America. e2v also operates a global network of sales and technical support offices, supported by local distributors and resellers. Further information is available from www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange END
BOAGGGZLGDKGLZZ More |
||
| 17-09-09 | RNS |
|
|
RNS Number : 2562Z e2v technologies PLC 17 September 2009 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: e2v technologies plc 2. Reason for the notification (please place an X inside the appropriate bracket/s): An acquisition or disposal of voting rights: (X) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation: Standard Life Investments Ltd 4. Full name of shareholder(s) (if different from 3.) : Vidacos Nominees 5. Date of the transaction (and date on which the threshold is crossed or reached if different): 11/09/2009 6. Date on which issuer notified: 15/09/2009 7. Threshold(s) that is/are crossed or reached: 3% 8. Notified details: A: Voting rights attached to shares
possible using the ISIN CODE
ISIN GB00B01DW905 Resulting situation after the triggering transaction
possible using the ISIN CODE
ISIN GB00B01DW905 B: Financial Instruments Resulting situation after the triggering transaction
Total (A+B) Number of voting rights % of voting rights
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information: 14. Contact name: Sally Weatherall 15. Contact telephone number: 01245-453621 This information is provided by RNS The company news service from the London Stock Exchange END
HOLILFVSATIDLIA More |
||